Informatics Corporation of America (ICA; www.icainformatics.com), providing clinicians with a single technology solution for accessing, evaluating and acting upon patient information across disparate systems, today announced that its A3Align Solution(TM) has been selected by Lourdes Hospital to provide a comprehensive EHR and tools to deliver better care. A 389-bed hospital in Paducah, Kentucky, Lourdes is part of the Catholic Healthcare Partners network.

“We selected ICA’s A3Align Solution(TM) for its ability to build upon our existing acute and ambulatory systems to align our hospital with physician practices. Its aggregation capabilities will give our providers easy access to a patient’s longitudinal record, with real-time access to results,” said Steven Grinnell, Regional CEO, Mercy Health Partners-Kentucky and President and CEO of Lourdes Hospital. “This will relieve our staff of the need to duplicate documentation and ensure that every patient’s chart is complete and up-to-date. Within six months, we anticipate having a single point of access for all clinical information, with significant cost and time savings.”

In the initial phase of the agreement, ICA will aggregate patient information from existing clinical systems, including Meditech Magic, Chart Maxx, PICIS, MIDAS, OBIX, Allscripts, Ulrich, and Fuji. Subsequent phases are slated to extend the solution’s functionality beyond aggregation.

“ICA’s flowsheet presentations, template forms, and communication capabilities will help Lourdes streamline provider workflow and align care across treatment settings,” said Gary Praznik, CIO of Lourdes Hospital. “With seamless access to clinical data and smoother clinical workflow, we expect to see marked improvements in patient and physician satisfaction.”

According to Gary Zegiestowsky, CEO of ICA, “We are pleased to partner with Lourdes Hospital in this exciting initiative and look forward to helping them achieve their vision of enhanced care. We are confident that our phased implementation approach will enable Lourdes to reach its near- and long-term goals with minimal disruption and risk.”

He emphasizes that decision-makers can turn to ICA for proven technology, adding, “Our A3Align Solution(TM) has a track record of rapid physician adoption and demonstrable results. By giving physicians the information they need when they need it, our technology helps healthcare enterprises reduce costs, improve the quality of care, and boost physician satisfaction and retention.”

ICA’s A3Align Solution(TM) is based upon technology developed over the course of 10 years by practicing physicians and informatics professionals at Vanderbilt Medical Center. It is installed at Bassett Healthcare’s enterprise of five hospitals and 27 clinics in Cooperstown, N.Y. ICA recently announced the Health Information Exchange of Montana and Northwest Healthcare will soon begin implementation of the A3Align Solution(TM) as a single-source platform for meeting enterprise and community needs in northwest Montana.

About Lourdes Hospital

Lourdes Hospital is sponsored by Catholic Healthcare Partners (CHP), one of the largest not-for-profit health systems in the nation. Located in Paducah, Kentucky, it serves as a regional referral center for a wide geographic area, including more than a dozen counties in western Kentucky, southern Illinois, southeast Missouri, and northwest Tennessee. Lourdes offers an extensive array of medical specialties and technologies typically found in much larger urban settings. Satellite clinics are located in a number of sites in western Kentucky.

About Informatics Corporation of America (ICA)

Informatics Corporation of America (ICA) was created with nationally renowned Vanderbilt Medical Center to take innovative technology developed by Vanderbilt physicians to the broader healthcare market. ICA builds on existing IT systems to offer a single technology solution for accessing, evaluating and acting upon patient information across all treatment settings. Visit www.icainformatics.com

CHICAGO, July 9 /PRNewswire-USNewswire/ — Blue Cross and Blue Shield of Illinois (BCBSIL) recently gave $960,000 in grants to 83 501(c)3 organizations in Illinois. In line with its mission, “to promote the health and wellness of our members and communities through accessible, cost-effective, quality health care,” BCBSIL’s giving focused mostly on community-based organizations that provide hands-on health services to the uninsured. BCBSIL also funded programs that provide human services and education to underserved communities in the state, as well as arts organizations. This was the first of two grant cycles that BCBSIL holds annually.

In addition, BCBSIL donated $90,000 in credits toward IBM Certified Used Equipment to 28 local nonprofits in collaboration with IBM. The non-profits used this “credit” to obtain needed laptops, desktops and monitors.

“Blue Cross and Blue Shield of Illinois is proud to support health and other much-needed services for those who may not have access otherwise,” said Clarita Santos, director of Community Health Initiatives at BCBSIL. “We have targeted many public health organizations that are making a real difference in communities, and we also are supporting programs that promote child health and wellness.”

For more information about BCBSIL’s charitable giving programs, contact Jennifer Tani at (312) 653-7159 or e-mail her at [email protected]. Visit http://www.bcbsil.com/about_us/involvement.htm to apply online for a grant. Applications for the second grant cycle are due September 30, 2008.

   The latest grantees are:   1. A Safe Place   2. Access Community Health Network   3. AGAPE Youth Network   4. Alexian Brothers AIDS Ministry   5. Alivio Medical Center   6. Alliance for Community Peace   7. American Indian Center (AIC)   8. American Lung Association of Illinois- Greater Chicago   9. Apna Ghar   10. Arab-American Family Services   11. Asian Health Coalition of Illinois   12. Association House of Chicago   13. Avenues to Independence   14. Between Friends   15. Blue Cap   16. Boys Town   17. BUILD   18. Care For Real   19. CASA of Williamson County   20. Cathedral Counseling Center   21. Centro San Bonifacio   22. Chicago Area Project   23. Chicago Christian Industrial League   24. Chicago Coalition for the Homeless   25. Chicago Family Health Center   26. Chicago Freedom School   27. Chicago House and Social Service Agency   28. Chicagoland Bicycle Federation   29. Childcare Network of Evanston   30. Children's Home + Aid   31. Christian Outreach of Lutherans   32. Christopher House   33. CoACH Care Center   34. Community Health Care Clinic   35. CommunityHealth   36. Connections for Abused Women and their Children   37. Deborah's Place   38. Developmental Services Center (DSC)   39. Edwards County Council on Aging   40. Family Health Partnership Clinic   41. Family House   42. Free People's Clinic   43. Global Girls   44. Goldie's Place   45. Hands of Hope Family Clinic   46. Holy Family Ministries   47. Housing Opportunities for Women   48. Howard Area Community Center   49. Infant Welfare Clinic   50. Inspiration Corporation   51. Japanese American Service Committee (JASC)   52. Korean American Community Services   53. Latinos Progresando   54. Lawrence Hall Youth Services   55. Legal Assistance Foundation of Metropolitan Chicago   56. Lifelink Charities   57. Mattoon Area Family YMCA   58. Music Institute of Chicago   59. Music Theatre Workshop   60. People's Resource Center   61. Precious Blood Ministry of Reconciliation   62. REST   63. Sarah's Circle   64. SisterHouse   65. SOS Children's Villages Illinois   66. Southwest Chicago PADS   67. Southwest Community Services   68. Special Olympics Illinois   69. Sudden Infant Death Services of Illinois   70. Teen Parent Connection   71. The ARK   72. The Bridge Youth & Family Services   73. The Center for Independence through Conductive Education   74. The Chicago Public Education Fund   75. The Infant Welfare Society of Chicago   76. The Monroe Foundation   77. The Youth Job Center of Evanston   78. Tri City Health Partnership   79. True Star Foundation   80. Umoja Student Development Corporation   81. White Crane Wellness Center   82. Will County Children's Advocacy Center   83. YOU CAN MAKE IT    About Blue Cross and Blue Shield of Illinois   

With more than 7 million members, BCBSIL (http://www.bcbsil.com/) is the largest health insurance company in Illinois. Started in 1936, BCBSIL is committed to promoting the health and wellness of its members and its communities through accessible, cost-effective, quality health care. BCBSIL is a Division of Health Care Service Corporation, a Mutual Legal Reserve Company (HCSC). HCSC is an independent licensee of the Blue Cross and Blue Shield Association.

Blue Cross and Blue Shield of Illinois

CONTACT: Bridget Houlihan of Blue Cross and Blue Shield of Illinois,+1-312-653-4668, [email protected]

Web Site: http://www.bcbsil.com/

Sigma-Tau Pharmaceuticals, Inc. is pleased to announce the acquisition of Chenofalk(R) (chenodeoxycholic acid) from the Germany-based, Dr. Falk Pharma GmbH. Chenofalk(R) is approved in Germany for the dissolution of gallstones, and Sigma-Tau’s German affiliate, Sigma-Tau Arzneimittel GmbH, will immediately assume distribution of this important medicine, ensuring there is no interruption in availability to patients.

The acquisition of Chenofalk(R) is important not only to ensure continued supply in Germany, but Sigma-Tau Pharmaceuticals also intends to accumulate the appropriate clinical and regulatory documentation required to support the filing of a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for the use of chenodeoxycholic acid (CDCA) in the treatment of Cerebrotendinous Xanthomatosis (CTX) disease. CTX is an extremely rare genetic disease which is believed to affect fewer than one hundred people in the U.S.

“We are pleased to add CDCA to Sigma-Tau’s rare disease portfolio. Sigma-Tau is committed to the development of medicines for patients with rare diseases, and the acquisition of Chenofalk(R) provides relief to patients concerned about a disruption in supply,” said Gregg Lapointe, Chief Executive Officer of Sigma-Tau Pharmaceuticals. “Acquiring the underlying clinical, manufacturing and safety data contained in the Chenofalk(R) dossier is also an important milestone in Sigma-Tau’s goal of ultimately securing FDA approval for the use of CDCA in patients with CTX.”

CTX is a metabolic disorder with no FDA-approved treatment in the United States. People with this disorder cannot break down certain cholesterols effectively. Consequently, these cholesterols accumulate in various areas of the body. Some features of CTX include chronic diarrhea during infancy, clouding of the lens of the eye (cataracts) developing in late childhood, progressively brittle bones that are prone to fracture, and neurological problems in adulthood, such as dementia, seizures, hallucinations, depression, and difficulty with coordinating movements (ataxia) and speech (dysarthria).

In 2007, Sigma-Tau obtained an Orphan Drug Designation from the FDA for the use of CDCA in CTX. Since then, Sigma-Tau has worked closely with the United Leukodystrophy Foundation (ULF) to better understand the impact of CTX disease on patients and the importance of proper newborn screening for the disease.

About Cerebrotendinous Xanthomatosis (CTX)

Cerebrotendinous Xanthomatosis (CTX) is a rare, autosomal recessive metabolic disorder caused by mutations in a gene called CYP27A1, which produces an enzyme called sterol 27-hydroxylase. Sterol 27-hydroxylase is required to turn cholesterol into bile acids, which are important in the absorption of fat in the intestine. In addition, when sterol-27 hydroxylase is not working properly, cholesterol and precursors of bile acids will accumulate in tissues throughout the body causing a variety of physiologic and neurological problems.

About Sigma-Tau Pharmaceuticals, Inc.

Sigma-Tau Pharmaceuticals, Inc. is a U.S. based, wholly owned subsidiary of the Sigma-Tau Group, and is dedicated solely to the global development and commercialization of medicines for patients with rare diseases. Sigma-Tau Pharmaceuticals, Inc. is based in Gaithersburg, Maryland.

Since 1989, the company’s products have been focused on rare diseases, kidney disease, and cancer. With more than 6,000 identified rare diseases that affect approximately 25 million patients in the U.S., Sigma-Tau places its considerable scientific resources behind the development and commercialization of compounds that benefit the few. The company has a substantial development program focused on transplant, cancer, inherited genetic disorders, malaria, and other areas of unmet medical need. For more information about the company, visit www.sigmatau.com.

About Sigma-Tau Group

Sigma-Tau Group is a leading research-based Italian pharmaceutical company with a 2007 consolidated turnover equal to approximately US$ 980 million and over 2,500 employees worldwide. Therapeutic areas in which Sigma-Tau Group’s research and development are focused include cardiovascular disease, metabolism, oncology, immunology, central and peripheral nervous system with 47 projects, 30 clinical indications studied with 17 proprietary molecules, most of which are new and original. For additional information about Sigma-Tau Group, please visit www.sigma-tau.it.

About United Leukodystrophy Foundation (ULF)

The United Leukodystrophy Foundation (ULF) is dedicated to helping patients and family members afflicted with various types of leukodystrophies including CTX. The ULF is committed to the identification, treatment and cure of all leukodystrophies through programs of education, advocacy, research and service.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=794519

 For more information, please contact: Marc Tewey Vice President of Commercial Operations Phone: 301-670-1518 Email: Email Contact

SOURCE: Sigma-Tau Pharmaceuticals, Inc.

By Jennifer Rich, Destin Log, Fla.

Jul. 9–ANew Orleans culinary legend is being reborn in Destin. Today, the doors to the long awaited Commander’s Palace will officially open to those looking for lagniappe, or a “little something extra.” The rich history of this legendary New Orleans’ fixture has found a new second home in Destin at Legendary’s HarborWalk Village. The enduring ante-bellum heritage of Commander’s Palace mingles with the refreshing charm of the Emerald Coast for an unparalleled dining experience. “We wanted it to have a beach attitude,” said Lally Brennan, of the famed New Orleans’ restaurant clan. Beach attitude and original taste is exactly what Commander’s is serving up in a quaint atmosphere with a modern twist, all with an uninhibited view of the emerald green waters of the Destin harbor. The multi-level restaurant offers something for everyone. The attached On the Rocks Bar is an ideal afternoon getaway for hand-crafted cocktails and world class appetizers. Located just yards from the HarborWalk docks, anglers can cap off their day in resort casual style or relax outdoors on the terrace. “I like to do a throwback to the classics,” Michael Richmond, bar chef and four year cohort of the restaurant, told The Log. Richmond’s bar creations are made to reflect owner Ti Martin’s passion for a good cocktail. On the Rocks makes drinks to order, but enjoys the opportunity to create something that will personalize a dining experience. One of Richmond’s signature cocktails is his own recipe that he calls La Primavera, after its refreshing combination of Hendrick’s Gin, Pomegranate Liqueur, watermelon puree and a touch of bar syrup. The full bar selection at Commander’s Palace comes with a growing international wine collection. With over 250 selections to choose from, beverage manager Greg Wescoat said that bottles run anywhere from $30 to those in the thousands. While the liquid refreshment from On the Rocks Bar stands in a class of it’s own, the food at Commander’s Palace is the star of the new operation. The menu at Commander’s features Haute Creole cuisine, with Floribbean and southern influences. Diners can get the down home feel with Shrimp & Grits Nassau or indulge in Island Spiced Rum Cake for a tropical touch. Martin said that a few staples from the original Commander’s Palace that carried over to Destin are the garlic bread, Turtle Soup, Creole Bread Pudding Souffle and Veal Chop Tchoupitoulas.

The menu accommodates appetites of all sizes and tables will always be on reserve for locals.

On Monday, Legendary employees and guests were privyed to a preview of what the restaurant has to offer.

Visiting from Baltimore, Md., Ginny Gue sampled the New Orleans Shrimp Remoulade and described it “like nothing I’ve had before.”

She was also pleased to find her favorite desert on the menu.

“Coconut is my favorite ice cream and I can’t find it up north,” Gue said.

Inside of this old and new inspired restaurant, diners are surrounded by designs reminiscent of old New Orleans brought to life by celebrated New Orleans artist Tim Trapolin.

Trapolin created the images for the menus and contributed the mural that is the backdrop of the Mermaid Room. The mural is a shrine to the original Commander’s Palace and features quirky depictions of Rik and Peter Bos and even New Orleans burlesque legend Evangeline, The Oyster Girl.

While the food, beverages and decor are top notch, the best reason to come to Commander’s is that every guest is treated like a rock star.

The waitstaff utilizes what they call “gang service.” The three tier system is a carefully choreographed presentation that ensures every guest receives personal attention — and an escort to the bathroom.

The Log spotted city councilor Sam Seevers enjoying Adelaide’s Spinach Salad with daughter and Legendary intern, Michael Seevers. Seevers was thoroughly impressed with the “intricate” service and “incredible” food.

“We definitely needed something like this in Destin,” Seevers said.

—–

To see more of The Destin Log or to subscribe to the newspaper, go to http://www.destin.com/.

Copyright (c) 2008, Destin Log, Fla.

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

Emisphere Technologies has reported encouraged findings from a clinical study assessing the oral delivery of GLP-1 peptide safely and effectively.

The study, conducted in 16 healthy male subjects, was designed to explore the pharmacodynamic effects of a single oral dose of GLP-1 administered 15 minutes prior to an oral glucose tolerance test. The study used a delivery-agent-based approach using Emisphere’s Eligen technology, and was conducted at University Hospital in Basel, Switzerland.

For the study, GLP-1 was formulated as a tablet with Emisphere’s delivery agent known as SNAC. The study also showed that pharmacological levels were achieved after a 2mg oral dose. The study demonstrated that the oral formulation of GLP-1 stimulated an early increase in fasting insulin and a decrease in fasting glucose as compared to placebo.

Emisphere’s Eligen technology is based on the development of small organic molecules, termed delivery agents or carriers, which interact non-covalently with macromolecules to enable their oral absorption.

Michael Novinski, president and CEO of Emisphere, said: “The study provides yet further evidence in the application of our Eligen technology as a potential solution to critical hurdles in pharmaceutical development. Hopefully, its use with GLP-1 in the treatment of diabetes will improve healthcare for millions of patients.”

By Adam Wilson, The Olympian, Olympia, Wash.

Jul. 9–New standards for angioplasties would harm smaller hospitals, such as Olympia’s Capital Medical Center, opponents said during a public meeting Tuesday in Tumwater.

Doctors and administrators from Longview, Skagit County, Yakima, Walla Walla and Vancouver, Wash., came to the Department of Health headquarters to speak against the proposal, which could take effect as soon as July 15.

An angioplasty is a potentially life-saving operation that involves sticking a balloon in a clogged artery. Only “expert” hospitals — those that perform angioplasties more than 300 times a year — would be allowed to perform the procedure except in emergency cases under the Department of Health proposal.

Because cardiologists expect to be able to perform angioplasties, the proposal would make it difficult for small hospitals to recruit the doctors, said Jody Carona, who helped organize a coalition of hospitals opposed to the rule changes.

The procedure costs an average of $64,000, which includes three years of follow-up treatment, according to a 2006 study published in the magazine Circulation. About 16,000 such procedures are performed statewide each year, Carona said.

The money from doing scheduled angioplasties helps pay for being set up for emergency angioplasties, she said.

“For the hospitals who are doing emergency procedures, it becomes very, very expensive,” Carona added.

The new rules would bar Capital Medical Center from performing non-emergency angioplasties. Providence St. Peter Hospital, also in Olympia, would be large enough to continue performing the procedures.

“Emergencies are more complicated. It’s more difficult, and yet we have excellent outcomes,” said Capital’s chief nursing officer, Lisa Moylan.

Offering elective angioplasty at two hospitals 10 minutes apart wouldn’t improve access for South Sound patients, said Dr. Bill Gavin, medical director of Providence’s Regional Heart Center.

Allowing more hospitals to offer the procedure would take revenue away from Providence, making it more difficult for the hospital to recover the costs involved in setting up for the procedures, he said.

“It would make no sense to damage that program,” Gavin said.

Many of those who testified against the proposed rules Tuesday said that 45 other states, including Oregon and Idaho, do not restrict the procedure. They cited a new study suggesting that performing as few as 200 scheduled angioplasties a year still ensures doctor expertise and patient safety.

Some of the state’s biggest hospitals disputed that claim.

Dr. Michael Ring of Sacred Heart Medical Center in Spokane said that study has yet to be published, but 400 procedures a year still is considered a “low-volume” hospital.

High volumes are linked to greater patient safety, said Dan Dixon of Swedish Medical Center in Seattle. “It’s not only all about access. It’s about balance,” he said.

The earliest the rule could go into effect is Tuesday. Before then, Tuesday’s comments will be sent to Health Secretary Mary Selecky, who will make a final decision about the proposal and could alter the rules.

—–

To see more of The Olympian, or to subscribe to the newspaper, go to http://www.theolympian.com.

Copyright (c) 2008, The Olympian, Olympia, Wash.

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

By Ginny Hoyle, The Herald-Sun, Durham, N.C.

Jul. 9–CARRBORO — Girls, get ready to rock!

The spunky six-member band Electric Ink and Spicy Wasabi manned — or, “wo-manned” — their instruments on the raised Carrboro ArtsCenter stage Tuesday afternoon during the fifth annual Rock & Roll Camp for Girls.

The camp, part of the nonprofit Girls Rock N.C. and run by local female rockers, provides a venue for girls 7 to 17 to create their own all-girl bands.

And instructors hold fast to a rule not often found in educational settings: the louder the better.

“This is rock ‘n’ roll, and rock ‘n’ roll is about being loud,” said instructor Beth Turner, who encouraged the 7-, 8-, and 9-year-old members of Electric Ink and Spicy Wasabi to up the volume.

The drummer’s fierce first beat inspired 9-year-old Hazel Pardington — also known as “Lil’ Obama” — to exclaim, “that shakes the ground!”

“That’s rock power,” Turner said.

“All-girl” rock power, to be exact — something that sat very well with 8-year-old Yasmin Frischemeier.

“My favorite part of the camp is being in a band with all girls,” said Yasmin, a vocalist. “When you’re in a band with all girls, you can really express yourself the way you want to.”

In addition to the camp’s elaborate jam sessions and rock lessons, the girls are encouraged to be self-confident, work as a team and recognize their own creativity through workshops in “zine-making,” clothes-making, recording, songwriting and self-expression, among others.

More than a dozen rock ‘n’ roll campers happily squirmed in their seats at two long tables in an upstairs classroom of the ArtsCenter on Tuesday afternoon during a workshop on body image.

The average American sees anywhere from 4,000 to 6,000 advertisements per day, said camp director Amelia Shull, and that can lead to a distorted view of the female body.

“These girls are still pretty little,” Shull said of the room filled with 7-, 8- and 9-year-olds. “They haven’t quite gotten to the issues of body confidence yet. The idea is to try to ask them why women are expected to work on their bodies for other people.”

Asked what’s most important to them at this age, the girls’ responses ranged from their families, to saving money for an iPod to a heart-shaped rock.

“That’s what you care about right now,” Shull said. “But what will you care about in 10 years?”

As girls become teenagers, they tend to “get more and more bogged down with their body,” said Shull, who teaches art to high-schoolers at Carolina Friends School.

Shull held up a magazine advertisement for a popular U.S. beer that featured a scantily-clad woman posed in the shape of a beer bottle.

“What do you think of this?” she asked the class.

“It’s freaky!” one girl yelled.

Another said, “They’re using us, women, as an object to make an ad and sell stuff to men.”

Another ad featured a photograph of a woman (from the neck down) wearing a Santa-inspired, skimpy bathing suit under a headline that reads: “Knock their stockings off. Put her [with “her” crossed out], them on your list.”

“Where’s her head?” Shull said of the all-body shot. “Remember what’s in your head — your brain! And we want you guys to go out into the world and make it better. We want you to have fun and we don’t want you to be angry at the world.”

Bass guitarist Chloe Grill, 9, said the workshop taught her about gender equality.

“By using women as objects, it makes it seem like we’re not equal, but I think women are just as good as men,” she said.

—–

To see more of The Herald-Sun, or to subscribe to the newspaper, go to http://www.herald-sun.com.

Copyright (c) 2008, The Herald-Sun, Durham, N.C.

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

Wyeth has reported that the European Commission has authorized a new 50mg Enbrel once weekly dosage regimen as an alternative to the currently approved 25mg Enbrel twice weekly regimen for the treatment of patients with moderate-to-severe plaque psoriasis.

Based on the outcome of the extensive European 318 study in adult patients with moderate-to-severe plaque psoriasis, the European Commission issued the marketing authorization for the EU for a once weekly 50mg Enbrel dosing.

The 318 study design comprised a primary endpoint of 75% improvement in psoriasis area and severity index score and included a number of measures to determine moderate-to-severe psoriasis patients’ quality of life. For 12 weeks one group received etanercept whilst the other group was given placebo.

After 12 weeks all patients were then prescribed etanercept in an open label period for a further 12 weeks. Study 318 achieved its primary endpoint at week 12, however patients continued to improve with etanercept treatment at week 24 demonstrating serious PRO impairment was largely abated with 64% ‘clear’ or ‘almost clear’.

Stevo Knezevic, chief medical officer of Wyeth Europe, said: “The study results confirm that Enbrel can achieve sustained efficacy both in the short and longer term. Furthermore the European Commission’s announcement affirms the important role that Enbrel can play in optimally managing the condition whilst providing greater flexibility and convenience for patients.”

WASHINGTON, July 9 /PRNewswire-USNewswire/ — Seniors across New Mexico are speaking out against proposed cuts to the Medicare Advantage program in legislation being considered in the U.S. Senate. The legislation (H.R. 6331) would cut $38 million from the Medicare Advantage program in New Mexico alone and severely cut back the areas where Medicare private fee-for-service plans can operate, adversely impacting the 9,000 New Mexico seniors enrolled in these plans.

Rose Horner, Eagle Nest, NM

“If it wasn’t for my Medicare Advantage plan I would be in a terrible mess. I don’t know what I would do if budget cuts are made to these programs. Medicare Advantage pays for a lot of things I would not be able to afford otherwise.”

Joann Gallegos, Las Vegas, NM

“My Medicare Advantage covers 80 percent of my medical bills. If budget cuts occur I will have to pay more out of pocket and could very well not be able to afford to go see a doctor anymore. I am a disabled woman who relies heavily on my Medicare Advantage plan.”

More than 65,000 Medicare beneficiaries in New Mexico currently rely on Medicare Advantage to meet their health care needs. These plans offer additional benefits and services that are not available in traditional Medicare, including reduced out-of-pocket costs; $0-premium comprehensive drug coverage; vision, hearing, and dental coverage; wellness programs; and disease management and care coordination programs. Medicare Advantage enrollees save an average of $90 per month – through improved benefits and lower out-of-pocket costs – compared to what they would pay in traditional Medicare.

A recent survey found that most seniors, including those in traditional Medicare, opposed cutting Medicare Advantage to fund the physician fix and believe these cuts would have a negative impact on Medicare Advantage beneficiaries. Click here to learn more about this survey: http://www.ahip.org/content/pressrelease.aspx?docid=23678.

America’s Health Insurance Plans – Providing Health Benefits to More Than 200 Million Americans

America?s Health Insurance Plans

CONTACT: Robert Zirkelbach of America’s Health Insurance Plans,+1-202-778-8493

Web Site: http://www.ahip.org/

HUNTINGTON BEACH, Calif., July 9 /PRNewswire-USNewswire/ — Amazingly, surfers have unknowingly held a key to prolonging the lifespan and quality of life for people with cystic fibrosis (CF), a fatal genetic disease that causes the body to produce thick, sticky mucus, which clogs the lungs and leads to life-threatening lung infections.

Several years ago, doctors in Australia noticed young surfers with cystic fibrosis had significantly healthier lungs. The doctors determined that inhaling saltwater mist has a powerful effect on rehydrating the lining of the lungs and allowing CF patients to more easily eliminate bacteria-contaminated mucus. This discovery led researchers to develop a hypertonic saline solution, which CF patients around the world now inhale every day. In essence, CF patients now mimic a “surf session” on a daily basis.

More than 70,000 CF patients face a daily battle, enduring hours of daily therapies and treatments to avoid the threat of mucus build-up in the lungs. While average life expectancy has doubled in the past 25 years to age 37 — due to advances in treatment and care — funding is still urgently needed to find the miracle drug leading to a cure.

The recent “saltwater” breakthrough treatment has led the Southern California Chapter of the Cystic Fibrosis Foundation to form a “PIPELINE TO A CURE” campaign to raise funds and to bring about global awareness of the unique bond between the sport of surfing and those with cystic fibrosis.

On July 19, 2008, the Cystic Fibrosis Foundation together with honorary co-chairs and surf legends Laird Hamilton and Dave Kalama will host an inaugural gala at the Hyatt Regency Huntington Beach, California, also known as “Surf City.”

Title sponsor PacSun and supporting sponsors the Kelly Slater Foundation, BJ’s Restaurants, the Tony Hawk Foundation, Wahoo’s Fish Taco, and Coast Benefit Consultants hope to generate a major groundswell to increase awareness and support for the Cystic Fibrosis Foundation. LACarGuy Mike Sullivan has donated a Toyota Prius for the opportunity drawing. Many silent and live auction items are “priceless” as the entire surf industry has gotten on board and donated many “epic” items.

Emcee Rick Dickert of Fox 11 Morning News and Good Day LA, auctioneer Shawn Parr of Go Country 105 FM will be joined by special musical guest acoustic SOCIAL DISTORTION at the event.

“This wonderful and direct connection between surfing and cystic fibrosis is unparalleled,” commented PIPELINE TO A CURE Co-Chair Jerry Hennessy. “Participating in the sport of surfing is actually good for CF patients, and we believe we can use the power and ‘soul’ of surfing to raise tremendous awareness and dollars for CF research.”

At the PIPELINE TO A CURE event, the Cystic Fibrosis Foundation will be honoring Wing Lam, Ed Lee and Mingo Lee, the owners of Wahoo’s Fish Taco, for their many years of support for the CF Foundation and other worthwhile causes.

Surf over to http://www.pipelinetoacure.com/ for more information and to view a YouTube(R) video of one very special surfer, named Emily.

About the Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the leading organization devoted to curing and controlling cystic fibrosis. Headquartered in Bethesda, Md., the Foundation funds CF research, has 80 chapter and branch offices throughout the country, and accredits a nationwide network of 115 CF care centers, which provide vital treatments and other CF resources to patients and families. To advance the search for a cure, CFF has invested nearly $300 million in promising scientific research in the biotechnology industry since 1998. As a result, the Foundation has more than 30 potential therapies in its drug discovery and development pipeline. Virtually every approved CF drug available today was made possible because of Cystic Fibrosis Foundation support. For more information visit – http://www.cff.org/.

Cystic Fibrosis Foundation

CONTACT: Colleen O’Higgins, Executive Director – Southern CaliforniaChapter, +1-714-938-1393, [email protected], or Laurie Fink, Director of MediaRelations, +1-301-841-2602, [email protected], both of the Cystic FibrosisFoundation

Web Site: http://www.cff.org/http://www.pipelinetoacure.com/

BETHESDA, Maryland, July 9 /Xinhua-PRNewswire/ — Chindex International, Inc. , an independent American provider of international healthcare services and Western healthcare products in the People’s Republic of China, today announced that its Healthcare Services division has formally launched its noncommercial China travel health information website, China Health Watch.

China Health Watch ( http://www.chinahealthwatch.org/ ) is a comprehensive website that provides travel health advice, vaccination advice, health services, news, and current health alerts for overseas travel to China. This site caters to both first-time travelers to China and experienced expatriates who have lived in the country for many years.

With a focus on the influx of foreign visitors this July and August for the 2008 Olympic games, China Health Watch was created by Chindex’s United Family Healthcare (UFH) to provide visitors and expatriates with complete travel health information for China. This information network covers all regions of the country, from Beijing to Guangzhou and Tibet to Xi’an.

The content of China Health Watch is edited by UFH physicians and includes travel health advice from other global sources such as the Centers for Disease Control and Prevention and the International Society of Travel Medicine

About Chindex International, Inc.

Chindex is an American healthcare company that provides healthcare services and supplies medical capital equipment, instrumentation and products to the Chinese marketplace, including Hong Kong. It provides healthcare services through the operations of its United Family Healthcare network of private primary care hospitals and affiliated ambulatory clinics in China. The Company’s hospital network currently operates in the Beijing and Shanghai metropolitan areas. The Company sells medical products manufactured by various major multinational companies, including Siemens AG and Intuitive Surgical, which are the Company’s exclusive distribution partners for the sale and servicing of color doppler ultrasound systems and surgical robotic systems respectively. It also arranges financing packages for the supply of medical products to hospitals in China utilizing the export loan and loan guarantee programs of both the U.S. Export-Import Bank and the German KfW Development Bank. With twenty-seven years of experience, more than 1,300 employees, and operations in China, Hong Kong, the United States and Germany, the Company’s strategy is to expand its cross-cultural reach by providing leading edge healthcare technologies, quality products and services to Greater China’s professional communities. Further company information may be found at the Company’s websites, http://www.chindex.com/ and http://www.unitedfamilyhospitals.com/ .

   For more information, please contact:     Judy Zakreski    Lawrence Pemble    Tel: +1-301-215-7777  

Chindex International, Inc.

CONTACT: Judy Zakreski or Lawrence Pemble, +1-301-215-7777, both ofChindex International

Web site: http://www.chindex.com/http://www.unitedfamilyhospitals.com/http://www.chinahealthwatch.org/

Denise Goodman is one of Long Island’s top experts on the travels of tomatoes: their sometimes long and very often circuitous trek from farm to plate.

The Manhasset resident is the proprietor of M&R Tomatoes in the New York City Terminal Market — the bustling Hunts Point cooperative in the Bronx — the largest food distribution center in the world.

It is in large part the lengthy route taken to the table — sometimes from the U.S. to Mexico and back — combined with what the government claims is insufficient record keeping in the produce industry, that has made it difficult to trace the source of a salmonella outbreak that has sickened nearly 1,000 people.

Federal health officials have pointed to tomatoes, but in recent days also expanded their focus to other salad bowl constituents — cilantro, jalapeno peppers, serrano peppers, scallions and bulb onions.

No tainted tomatoes found

Goodman disagrees that tomatoes ever were involved in the outbreak, based on growers’ assurances and the government’s inability to find a single tainted tomato. “I know it’s not tomatoes because the evidence just isn’t there,” said Goodman, who supplies tomatoes and other fresh produce to small supermarkets, diners and vegetable vendors on Long Island and elsewhere in the tri-state.

But it is the vastness of the system in which fresh produce is grown, harvested, processed and distributed that impedes government inspectors attempting to trace a specific bacterial strain when it invades the food supply, experts say.

Decades ago, food production was a local enterprise — from nearby farms to small mom-and-pop stores. Now, when food arrives in supermarkets, it’s not unusual for it to have traveled across numerous state lines, and increasingly, across several international borders.

Politicians, watchdog groups and food policy experts point to a regulatory system that has not kept pace with the complexity of modern food distribution. Inspectors are repeatedly stumped when attempting to pinpoint where contamination occurs.

The movement of produce in the United States is extraordinarily complex and much of it driven by consumer demand for nutritional products year round, said Robert Gravani, professor of food science at Cornell University in Ithaca.

“There’s no seasonality to produce any more,” Gravani said. “If you’re willing to pay for it, you can have it, regardless of the season. And that’s a good thing in terms of nutritional value. But we don’t want people getting sick.”

Consumer confidence falling

Goodman is able to maintain a bounty of fresh tomatoes for her customers by following growing seasons in a variety of U.S. regions and Mexico. But she said one bacterial scare after another is destroying consumer confidence and harming business. Still, she is quick to defend American fresh produce.

“It is one of the safest food supplies in the world. And not to minimize the problem with all of the cases,” she said of people sickened by salmonella, “the number is small compared to the amount of fresh produce that’s eaten. We’re doing a pretty good job.”

Top federal scientists and seasoned food safety inspectors have mounted an exhaustive search for the source of Salmonella saintpaul, a strain so rare it infected only three people nationwide last year. As of yesterday, more than 990 cases had been identified in a stepped-up probe involving the Food Emergency Response Network, a consortium of 100 state laboratories working with federal inspectors. The cases have all been linked to a single genetic fingerprint.

In Nassau, three illnesses have been confirmed, with another two in Suffolk where two more are pending. All told, 28 people have been sickened in New York since April, yet authorities concede far more people are likely to have been sickened than are officially reported.

Dr. David Acheson of the Food and Drug Administration acknowledged last week that even though tomatoes were under a spotlight, other produce items are also suspect. Because so many cases in the Southeast involved Mexican restaurants, inspectors are examining fresh guacamole, salsa and the condiment pico de gallo. But Acheson emphasized, “We are still hot on the trail of tomatoes.”

Have tomato will travel

In a recent briefing, he said the FDA during the course of this investigation was surprised to learn about extensive repackaging of U.S.-produced tomatoes for retail distribution. Investigators found some American tomatoes are picked, boxed and sent to Mexico for sorting and repackaging. The products bear stickers stating they were grown in the United States.

Sen. Charles Schumer (D-N.Y.) has authored federal legislation that would house food safety and inspection in a single agency. The duties currently are spread throughout a variety of government entities, with most handled by the U.S. Department of Agriculture, which inspects meat and poultry, and the FDA, which oversees produce.

Many multi-ingredient foods that cross jurisdictions are not inspected. An estimated 13 percent of the food supply is imported from abroad but 98.7 percent of those items are never inspected, a study earlier this year found.

Regulation not tough enough

“We have 12 agencies that regulate food safety,” Schumer told Newsday. “But the system is not tough enough,” he said, explaining that many inspections are pre-announced.

“With meats they’ll announce. They don’t do surprise inspections and none of them have a system for tracing when there’s an outbreak. So when you have one of these crises … you can’t trace it and millions of dollars wind up being lost.”

Schumer describes U.S. food inspection as “still back in the days of Upton Sinclair,” referring to the author of the 1906 blockbuster “The Jungle,” a book that revealed shocking practices in the meatpacking industry and led to the creation of federal food inspections.

Caroline Smith DeWaal, food safety director at the Center for Science in the Public Interest in Washington, has urged the FDA to institute emergency regulations requiring that all U.S. produce be traceable.

Even when tomatoes are used in factory-canned tomato sauce, DeWaal said, the government should be able to trace each piece of fruit back to its farm of origin. The center has tracked more than 700 outbreaks of food-borne illnesses linked to fresh produce since 1990.

Yet Suffolk County Health Commissioner Dr. David Graham worried that fear of salmonella could adversely affect produce suppliers and processors, vital to maintaining a choice of healthy fruits and vegetables.

“We want to inform the public of a risk that may be real, but it has to be done with all the best scientific evidence. That’s always a challenge in an outbreak situation. You don’t want to damage someone’s livelihood or put out preliminary information that is not accurate, ” Graham said.

Losses in the tomato industry have been considerable. Goodman has not yet estimated her own. Some industry assessments have been as high as $250 million. Goodman said tons of unaffected tomatoes were trashed as people panicked. In June, she donated tomatoes to charities. “We gave some of them to the homeless.”

States affected

Since April, 991 people in 41 states, the District of Columbia and Canada have been affected with the Salmonella saintpaul strain as of 9 p.m. Monday.

State People affected

Alabama 2

Arkansas 13

Arizona 47

California 8

Colorado 13

Connecticut 4

Florida 2

Georgia 24

Idaho 4

Illinois 95

Indiana 14

Iowa 2

Kansas 17

Kentucky 1

Louisiana 1

Maine 1

Maryland 29

Massachusetts 24

Michigan 7

Minnesota 10

Missouri 12

New Hampshire 4

Nevada 11

New Jersey 9

New Mexico 98

New York 28

North Carolina 10

Ohio 8

Oklahoma 24

Oregon 10

Pennsylvania 11

Rhode Island 3

South Carolina 1

Tennessee 8

Texas 382

Utah 2

Virginia 29

Vermont 2

Washington 4

West Virginia 1

Wisconsin 11

District of Columbia 1

Canada 4

SOURCE: Centers for Disease Control

The hunt for red tomato

One possible scenario FDA officials are investigating as part of the Salmonella saintpaul outbreak:

1. Tomatoes grown in Florida are shipped to Mexico.

2. The tomatoes are washed, sorted and packed.

3. Tomatoes are shipped back to Florida for national distribution.

THE LATEST

WHAT THEY KNOW

The outbreak, traced to early April, is not over, and continues to expand, with more than 990 confirmed sickened.

People are still getting sick despite mass avoidance of Mexican, Central and South Florida tomatoes, whose season has already passed. Fresh tomatoes were the first to be suspected though, throughout the outbreak, the FDA has given the all-clear to grape, cherry, on-the-vine and homegrown tomatoes.

FDA recommends consuming red round, roma and plum tomatoes only if they come from particular U.S. states, certain Florida counties and states of Mexico, or other foreign countries that it lists at www.fda.gov/oc/opacom/hottopics/tomatoes.html

Other vegetables are suspects, especially those used in fresh salsa, guacamole and pico de gallo. Salsas in jars, cans or plastic containers and sold in supermarkets are not under investigation. There are clusters of cases in the Southwest among people who dined at restaurants that serve Mexican-style foods.

Some food producers have maintained insufficient records, which make tracing produce difficult. U.S. regulators want more producers to move into “the digital age.”

Of the 2,500 known strains of salmonella, the one involved in the outbreak — Salmonella saintpaul — is extremely rare. Fecal matter is often the source of the bacteria.

WHAT THEY DON’T

Federal inspectors are still trying to establish the exact source and learn how, where the bacteria got into the food supply.

Possible vectors include irrigation on a farm, birds or other animals passing through planted fields, workers in a processing plant, tainted equipment or water used to wash produce.

How long the outbreak will continue.

New research says one-quarter of the adult population in China is now considered overweight or obese, and that number could double in the next 20 years.

Researchers published the findings in the journal Health Affairs. They blamed the weight gain on declining rates of physical activity and a diet more similar to their Western counterparts.

If the Chinese government fails to take action soon, the report warns adult obesity rates could double by 2028.

Researchers say the current obesity trend in China could symbolize the future for obesity occurring in the rest of the developing world.

This latest obesity study, led by Professor Barry Popkin, studied 20,000 people across the country and the findings have worrying health implications.

The proportion of overweight and obese residents has grown steadily since China’s rapid economic changes started. The report also pointed out that the rates of hypertension and diabetes are also rapidly increasing.

Already about 80 percent of deaths in China are due to non-communicable diseases like heart disease and cancer. Contributing factors can include an unhealthy diet and weight.

The BBC’s Asia analyst, Jill McGivering, said obesity has often been linked with China’s new affluence and urban, more Westernized lifestyles.

But this survey contradicts that theory, and points out that low-income people in rural areas are now more likely to be overweight compared those on higher incomes in the cities.

That finding replicates the current situation in the developed world, where poverty and obesity are often related. Professor Popkin said that China’s traditional balanced diet was frequently giving way to an eating regimen high in oil and meat.

Others blame the obesity outbreak on less exercise: agriculture is more mechanized, and cars, motorbikes and tractors are replacing bicycles. Chinese adults are also watching much more television.

The Chinese government says it is aware of the growing health problems due to a 25 percent rate of adult obesity. But critics say, so far the government has failed to focus on the need to strive for a healthy weight.

—

On the Net:

Health Affairs

Epeius Biotechnologies has announced that Rexin-G has received orphan drug designation from the FDA for the treatment of osteosarcoma.

The FDA granted the orphan drug status based on several criteria, including the rarity, seriousness, and current lack of effective therapies for metastatic osteosarcoma, as well as the scientific and medicinal merit of Rexin-G.

The US orphan drug designation provides seven years of market exclusivity for Rexin-G, a reduction in fees and taxes, and additional regulatory support for R&D initiatives.

The Indiana Health Information Exchange (IHIE) today announced that Saint Anthony Medical Center, Saint Anthony Memorial and Saint Margaret Mercy are now using its results delivery / clinical messaging service, called the DOCS4DOCS(R) service.

These hospitals serve patients in northwest Indiana and make up the Northern Indiana Region of the Sisters of Saint Francis Health Services, Inc. (SSFHS) health system, a charter member of IHIE.

Saint Anthony Memorial is located in Michigan City, primarily serving La Porte and Porter Counties in Indiana as well as Berrien County, Michigan. Saint Anthony Medical Center is located in Crown Point and serves Lake County and surrounding communities. Saint Margaret Mercy has hospital locations in Hammond and Dyer serving locations in northwest Indiana and southeast Chicago.

“We are pleased to add these four hospitals to our growing network,” said Dr. J. Marc Overhage, President and CEO of the Indiana Health Information Exchange, Director of Medical Informatics at the Regenstrief Institute, Inc. and Regenstrief Professor of Medical Informatics at the Indiana University School of Medicine. “These additions to our network demonstrate the value of the service and reinforce the commitment of these communities to provide the best health care possible for their patients.”

The DOCS4DOCS service is a sophisticated, secure, Web-based service that delivers clinical reports such as transcription, radiology and laboratory to physician offices, replacing traditional delivery systems such as courier and postal mail. It was developed by the Regenstrief Institute and is run in conjunction with IHIE.

“IHIE is a significant component of health-care information technology and it greatly advances our network of hospitals to provide efficient, seamless and top-notch care for our patients,” said Kevin Leahy, president and CEO of Sisters of St. Francis Health Services Inc.

“The SSFHS Northern Indiana Region hospitals have been eager to implement the services of the Indiana Health Information Exchange for patients and physicians in the region,” said Gene Diamond, Chief Executive Officer of the SSFHS Northern Indiana Region. “For individual patients, access to good care becomes easier and safer when records can easily be shared. For the medical staff, the confidential, clinical messaging results in greater time efficiency in providing patient treatment.

“Having quality information at the point of care is essential to providing the best patient treatment,” Diamond said.

Marla Hoyer-Lareau, assistant vice president of Ambulatory Services at Saint Margaret Mercy in Hammond and Dyer said, “We are excited about our participation in the IHIE network. We are looking forward to providing this service to our physicians. Having immediate access to clinical information will expedite the care for our patients.”

The DOCS4DOCS service is one of the nation’s most respected clinical messaging services; 30 hospitals in Indiana are sending on average over 1.4 million messages each month to approximately 10,000 Indiana physicians.

In addition to the Sisters of St. Francis Health Services, Inc., IHIE’s other charter hospitals and hospital systems are Clarian Health, Community Health Network, St. Vincent Health and Wishard Health Services.

About the Indiana Health Information Exchange

Indiana Health Information Exchange, Inc. (IHIE) is a non-profit corporation formed by the Regenstrief Institute, private hospitals, local and state health departments, BioCrossroads and other prominent organizations in Indiana. It is dedicated to supporting communities by providing services that enable the right medical information to get to the right provider at the right time. To learn more, visit www.ihie.com.

About Sisters of St. Francis Health Services, Inc. and the Northern Indiana Region

The Sisters of St. Francis Health Services, Inc. owns and operates a network of 13 hospital campuses in Indiana and Illinois. SSFHS is one of the largest healthcare systems in Indiana.

SSFHS hospitals in the Northern Indiana Region are Saint Margaret Mercy, Hammond and Dyer; Saint Anthony, Crown Point; Saint Anthony Memorial, Michigan City and Franciscan Physicians Hospital, LLC, (a physician hospital partnership) in Munster.

By Mary Jo Balasco

The Battle of Huck’s Defeat will be from 10 a.m. to 5 p.m. Saturday and 11 a.m. to 4 p.m. July 13 at Historic Brattonsville, 1444 Brattonsville Road, McConnells.

Three significant battles of the Revolutionary War in the Carolina backcountry will be re-enacted. During the event, visitors can see how soldiers and civilians of the Carolina Piedmont survived the war. Activities include music, firearms demonstrations, talks by noted experts and examples of camp life.

Youth can explore the children’s encampment area and play with historic toys and games, participate in military drills and take part in a Revolutionary War camp.

Cost is $10 adults; $8 seniors; $5 youth ages 4 to 17; and free for children 3 and younger. CHM members will receive a $2 discount. For details, call 684-2327 or visit www.chmuseums.org.

P.J. Bruson to perform on Thursday in Rock Hill

P.J. Brunson will perform at 6:30 p.m. Thursday at Fewell Park, 1204 Alexander Road, Rock Hill. The concert is part of Rock Hill Parks, Recreation and Tourism’s Summer Concert in the Park series.

Brunson is a singer, guitarist and pianist whose voice has been compared to Joan Baez’s. She has played clubs and special events in North and South Carolina and has opened for the Charlotte Pops and Lyle Lovette. For details, call 329-5645 or visit www.rockhillrocks.com.

Fort Mill youth thespians will stage ‘Pollyanna’

The Fort Mill Community Playhouse will have a youth production of “Pollyanna” at 7:30 p.m. Thursday, Friday and Saturday and 3 p.m. July 13 at the theater, 615 Banks St., Fort Mill.

Pollyanna, a young orphan, goes to live with her wealthy but harsh and stern Aunt Polly. Pollyanna uses her “Gladness Game,” taught to her by her father, to transform the dispirited New England town into a pleasant place to live. The show has a cast of more than 20 youth and is directed by Susan Windham Capotosto of Fort Mill.

Tickets are $9 adults and $6 seniors and students. Advance tickets are available online at www.fortmillplayhouse.org or may be purchased with check or cash at Crossings, 102 Academy St., Fort Mill. For details, visit the website or call 548-8102.

Shakespeare shows presented by Young Yorkville Players

The Young Yorkville Playerswill present “The Shakespeare Project” and “The Fifteen Minute Hamlet” at 8 p.m. July 18, 19, 25, 26 and at 3 p.m. July 20 and 27.

In “The Shakespeare Project,” adapted by James Zager, the most famous scenes and monologues are taken from a selection of Shakespearean works and presented in a contemporary style with new interpretations. In “Fifteen Minute Hamlet,” Tom Stoppard’s version takes the most famous and best- loved lines from Shakespeare’s “Hamlet” and condenses them into a hilarious 15-minute version.

Tickets are $8 adults and $5 children and may be purchased at the door. For details, call (866) 334-0064 or 980-7412 or visit www.yorkvilleplayers.com.

Evangelistic event planned in Lake Wylie area

An evangelistic event for residents and neighbors of Lake Wylie’s Oakridge Community will be from 4 to 8 p.m. Saturday in an open field along Oakridge Road.

The event is coordinated by the Rev. Wanalyn Barnette, an associate minister of Liberty Hill A.M.E. Zion Church, Lake Wylie. The theme is REACH – Receive all into the family of God; Educate unbelievers in the way of the Lord; Always show love and compassion; Christ-like attitudes everywhere we go; and Help those in need.

The event is free and will include food, games, give-a-ways and crafts. Contributing sponsors are Carolina Panther Thomas Davis and Piedmont Medical Center.

The churches participating are Liberty Hill A.M.E. Zion Church, Lake Wylie; China Grove A.M.E. Zion Church, Rock Hill; Zoah A.M.E. Zion Church; News Loves Chapel A.M.E. Zion Church, Lake Wylie; New Home A.M.E. Zion Church, York; and Clover A.M.E. Zion Church. For details, call Barnette at (803) 493-3261 or e-mail [email protected].

Shag lessons offered at Gold Hill YMCA

Beginner shag lessons are offered from 7:30 to 9:30 p.m. beginning Wednesday at the YMCA at Gold Hill Road in Fort Mill. Lessons run for five weeks. Cost is $125 per couple and $65 for singles. Instructors are Tommy and Gail Davis. To register, call 548- 9622.

Auditions scheduled for local play festival

The Rock Hill Community Theatre is having auditions for its annual Down Home Play Festival, featuring original plays by local and regional playwrights.

Six one-act original plays will be directed by Winthrop University theater students under the supervision of Russell Luke. Audition dates and times are 5 to 7 p.m. July 13 and 7 to 9 p .m. July 14 in room 103 of Johnson Hall. Appointments are not necessary.

The theater is seeking male and female actors ages 14 and older. Actors can have a prepared piece or read from a provided scene. Previous acting experience is not required. Performance dates will be Aug. 14 through 17. For details, contact Luke at [email protected].

Special events planned for local reading program

All York County libraries will offer a free vacation reading program for ages 3 to 12 through Aug. 1. For details, visit www.yclibrary.org or call 981-5888. Children can keep track of minutes read or being read to and will receive prizes when they meet goals.

A partial program schedule is:

* Itty Bitty Baby Bugs, for babies 23 months and younger and their caregivers, 10 a.m. July 17 at the York County Library. Call 981-5888 to register. Bring babies to a wiggly, giggly story time filled with stories, rhymes and songs about our smallest creatures.

* Toddler time, for ages 24 to 35 months, 10 to 11 a.m. Thursdays at the Fort Mill Public Library. A weekly story time with songs, finger plays and movement activities for toddlers and their parent or caregiver.

* Rags to Riches Theatre presents “Bug Juice,” 1, 2:30 and 4 p.m. Tuesday at the Fort Mill Public Library; 1, 2:30 and 4 p.m. Wednesday at the York County Library; 10:30 a.m. Thursday at the Clover Public Library; 2:30 and 4 p.m. Thursday at the York Public Library; and 10:30 a.m. Friday at the Lake Wylie Public Library. The theater group gets the audience involved with a fly named Malaria.

* Jumping Jitterbugs, a story time for ages 24 to 35 months and their caregivers, 10 a.m. Tuesday and 4 p.m. July 21 at the York County Library. To register, call 981-5888.

* Insect-O-Mania, for ages 10 to 12, 3 p.m. July 29, York County Library, Rock Hill. Learn about the life of bees from a local beekeeper and make an earthworm hotel. To register, call 981-5888.

* Creepy, Crawly Critters, for ages 6 to 9, 11 a.m. July 22 at the York County Library. To register call 981-5888. Explore the lives of good and bad bugs with a special guest, The Orkin Lady, become a certified master bug hunter and make insect crafts.

* Evening book club for adults, 7 to 8:30 p.m. Thursday at the York County Library. Join other book lovers to discuss “Between Georgia,” by Joshilyn Jackson. To register and reserve a copy of the book, call 981-5825.

Family story time, story time for children of all ages accompanied by an adult, 4 p.m. Thursdays, beginning this week through July 31 at the York County Library.

The summer reading program for teens also will run through Aug. 1, with programs, prizes and food for rising sixth- through 12th- graders. Some programs require advance registration. A sample of programs are listed below. For a complete schedule visit www.yclibrary.org or call 981-5830. Related events include:

Teen bling jewelry workshop, for rising sixth to 12th graders, 11:30 a.m to 1 p.m. Saturday at the Lake Wylie Public Library; call (803) 831-7774 to register. The workshop also will be from 2:30 to 4 p.m. Saturday at the York Public Library, call 684-3751 to register. Learn how to make earrings using wire, jewelry findings and tools. Each participant will make at least three pairs of earings.

* Teen Advisory Board, 5 to 6:30 p.m. Tuesday at the York County Library and 2 to 3 p.m. July 16 at the York Public Library. The teen advisory board selects materials for the young adult collection and plans events for teens.

* Anime Club, 2 to 4 p.m. Tuesday at the York County Library. Join other fans to view and discuss anime and manga, hear guest speakers and share work.

* Rock On with Rock Band, for rising sixth- to 12th-graders, 5:30 to 7:30 p.m. Monday at the York County Library. Teens can explore their inner rock star with Wii’s “Rock Band” and other video games.

* Origami for teens, for rising sixth- to 12th-graders, 3 to 4:30 p.m. Wednesday at the York Public Library. A beginner’s class in the ancient art of paper-folding with origami master Marsha Dupre. To register, call 684-3751.

Green teens, an altered clothing workshop, for rising sixth through 12th graders, 9:15 a.m. to 3:15 p.m. July 14 at the York County Library, Rock Hill. Call 981-5860 to register. Participants can create a vest from old jeans. Bring a bagged lunch; drinks and desserts are provided.

Library locations are:

* The York County Library, 138 E. Black St., Rock Hill, 981- 5858.

* The York Library, 21 E. Liberty St., York, 684-3751.

* The Clover Library, 107 Knox St., Clover, (803) 222-3474.

* Fort Mill Library, 1818 Second Baxter Crossing, Fort Mill, 547- 4114.

* The Lake Wylie Library, 185 Blucher Circle, Lake Wylie, (803) 831-7774.

Computer classes offered at Charlotte sites

Panorama Computer Learning, a non-profit computer literacy organization, will have the following classes:

Microsoft 3-in-1 computer class, 9 a.m. to 3 p.m. Saturday at the Staybridge Hotel, Arrowood Road, Charlotte, or 9 a.m. to 3 p.m. July 16 at Wingate Inn Hotel, 760 Galleria Blvd. Cost is $50.

How to start and fund a 501 (c) (3) non-profit organization, 9 a.m. to 1 p.m. July 19, Holiday Inn Express, Arrowood Road, Charlotte. Cost is $75 per person or $ 120 per couple and includes workbook.

To register for classes or for details, call Susan Woods at (704) 968-2769 or visit www.PCLinc.org.

Fort Lawn center hosting computer training

Fort Lawn Community Center will offer the following computer classes from 8:30 to 11:30 a.m. during July and August at the center, 5554 Main St., Fort Lawn. To register, call the center at (803) 872-4462.

* Hallmark, Wednesday, $20.

* Word level 1, July 16 and 17, $30.

* Digital camera, July 23, $25.

* Excel level 1, July 24 and 31, $30.

* PowerPoint level 1, Aug. 6 and 7, $30.

* Digital Scrapbooking, Aug. 13 and 14, $30.

* Basic computer, Aug. 20 and 21, $30.

* Word level 2, Aug. 27 and 28, $30.

Cheerleader camp is July 14 to 17

Small Fry, Pee Wee and Gra Y cheerleaders will have a week-long cheerleading camp from 5:30 to 7:30 p.m. July 14 through 17 at Northwestern High School, 2503 W. Main St., Rock Hill.

Registration is $45 for YMCA members and $50 for non-members. Register at the YMCA, 402 Charlotte Ave., Rock Hill. For details, call Mike Herndon at the YMCA, 329-9622.

Thrift store group plans sales this week

Thrift Store Ministries of Western York County, 31 N. Congress St., York, will have a buy-one-get-one-free sale on all jewelry and single dishes this week. The store needs donations of furniture, clothing, appliances and other items. Volunteers are needed.

Store hours are 9 a.m. to 5 p.m. Monday, Tuesday, Thursday and Friday and 9 a.m. to noon Saturday; the store is closed Wednesday and Sunday. Thrift Store Ministries serves needy families in the York school district. For details, call 628-0808.

Families, alumni plan local gatherings

The following families and alumni announce reunions:

The descendants of Easter and J.C. McMullen are having a family reunion Aug. 29 through 31. Registration will be from 6 to 9 p.m. Aug. 29 at Cherry Park. For details, call Bobbie McMullen Marshall at 329-6228 or Joanne McMullen Wright at 329-4211.

The descendants of the late William Thomas Williams and his wife Annie Graham Williams will have a family reunion at 6 p.m. July 19 at Neely’s Creek Associate Reformed Presbyterian Church, 974 Neelys Creek Road, Rock Hill. A picnic supper will begin at 6:30 p.m. and a business meeting will follow. Each family is asked to bring a picnic basket and tea. For details, call Eugene Mitchell at 327-5653.

The Emmett Scott High School Class of 1967 will meet for its monthly birthday fellowship dinner at 5:30 p.m. July 14 at Chilli’s Bar and Grill, 630 Tinsley Way, Rock Hill.

Lionesses, adoptive familiesare among local meetings

The following groups will meet:

The National Association of Retired Federal Employees will meet Tuesday at Firebonz All American Barbecue and Grill, 2445 Cherry Road, Rock Hill. Lunch will be at 11:30 a.m. and a business meeting will be at noon. Speaker will be Moses Moultrie, District Field Officer.

The Southern Piedmont Adoptive Families of America will meet at 6:30 p.m. Tuesday in the first-floor temporary conference room of the Catholic Diocese Pastoral Center, 1123 South Church St., Charlotte. A welcome and introduction for new members begins at 6 p.m. The program will be a daddy panel discussing adoption from a father’s point of view. For details, visit www.spafa.org or call Elaine Lane at 548-7668.

The Lake Wylie Lioness Lions Club will meet at 11:30 a.m. Friday at the River Hills Country Club, 1 Country Club Drive, Lake Wylie. Guest speaker will be Barbara Beckham, District Governor 32D. To attend the meeting or join the group, call Olivia Goodell at (803) 831-5833.

Historic Rock Hill will have a membership and community meeting at 7 p.m. July 15 at the Rock Hill City Hall, 155 Johnson St. Speaker will be Stephen Turner of Rock Hill. Turner will show a collection of early Rock Hill postcards and photographs. The program is free and open to the public.

The Marine Corps League, consisting of retired and veteran Marines, will meet at 7 p.m. Tuesday at the Veterans of Foreign Wars, 732 W. Main St., Rock Hill. Meetings are on the second Tuesday of every month. Visitors are welcome. For details, call Don Hicks at 517-7253 or 328-1054.

The Private Thomas Caldwell Camp No. 31, Sons of Confederate Veterans will meet at 7 p.m. Thursday at the McCelvey Center, 212 E. Jefferson St., York. Speaker will be Mark Vogl, graduate of the Citadel, former Army combat arms officer, former college professor and political aide who has traveled throughout the United States and Europe. Vogl’s first book, “Military Lessons of the Civil War,” was published in the spring of 2007 and his second book will be published this fall, “Clear for Action, An Introductory History of the Confederate States Navy and the War for Southern Independence.” For details, call Kirk Carter at (704) 739-2964 or Jimmy Cagle at (803) 222-4372.

The Henry’s Knob Group of the South Carolina chapter of the Sierra Club will have its summer picnic at 6 p.m. Thursday at Cherry Park, in the picnic area near the playground. Members should bring supper, beverages and club photos. For details, call Mary Keenan at 327-9610. Guests are welcome.

The Newcomers Club of York County will meet at 11:30 a.m. Wednesday at the Pope John Center at the Oratory, 434 Charlotte Ave., Rock Hill. The program, The Organic Alternative, will be presented by Dani Goldfischer and Rachel Kitchen of Earth Fare. Lunch will be a Fourth of July-style barbecue for $12 per person. The club is open to all women new to York County. Monthly group activities include book club, Euchre, supper club, Mah-Jongg, bridge, golf and others. For details, call Dianne at 325-4648.

Support groups help with life’s issues

These support groups are meeting:

A caregivers support group will meet from 10 to 11:30 a.m. Thursday at Pleasant Grove United Methodist Church, 2868 Gaston Farm Road, Richburg. Caregivers can share joys, challenges and ideas. The group meets the second Tuesday of each month. To register or for details, call Grace Waddell at Agape Hospice at 329-4544 or at (866) 202-6342 or e-mail her at [email protected].

The National Alliance on Mental Illness will have a support group meeting from 6 to 7 p.m. Tuesday at Oakland Avenue Presbyterian Church, 421 Oakland Ave., Rock Hill. Parents of children and teens will meet in the education building room 202. Child care is available in the nursery. The support group is for parents and caregivers with children who have emotional and behavioral difficulties. For details, call Carol Mapp at 324-0780.

The South Carolina Spinal Cord Injury Association’s York County support group meeting will be at 7 p.m. Tuesday at Piedmont Medical Center Women’s Center auditorium. The group provides support through education and shared experience to those living with spinal cord injuries and to their families and caregivers. For details, call Bob Alders at 366-5659 or e-mail him at [email protected].

The Rock Hill Parkinson Support Group will meet at 1:30 p.m. July 16 in the cafeteria at HealthSouth of Rock Hill, 175 Amendment Ave., Rock Hill. Meetings are the third Wednesday of each month. The program will be “Talking to your children and grandchildren about Parkinson’s,” by Janice Broach from Hospice Care of S.C. For details, call Kris Kessling at 327-8442 or Don Robertson at 324- 8861.

Therapeutic art program offered for kids who grieve

Hospice and Community Care will have a therapeutic art project for grieving children, Project HOPE, from 9 a.m. to 5 p.m. July 18 and from 10 a.m. to noon July 19 at the campus, 2275 India Hook Road, Rock Hill. Project HOPE, healing ourselves through personal expression, is an outlet for grieving children to express grief in a healthy, creative way and to raise awareness for grieving children and teens.

Bereaved children are invited to create works of art with the assistance of a grief counselor and local artists. The program is free. Registration is required by calling the bereavement counseling department at Hospice and Community Care at 329-1500.

[email protected]

Deadline for Tuesday and Thursday columns is 5 p.m. two business days before publication. Deadline for Sunday is 5 p.m. Wednesday.

(c) 2008 Herald; Rock Hill, S.C.. Provided by ProQuest Information and Learning. All rights Reserved.

CLEVELAND, July 9 /PRNewswire/ — Hyland Software, developer of the OnBase(R) enterprise document management software suite, announced that SSM Health Care has experienced immediate results since the deployment of OnBase in March. Based in St. Louis, Missouri and offering services in four states, SSM is a forward-thinking health care provider to patients regardless of their ability to pay.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070110/CLW019LOGO )

As a core component of SSM’s electronic health record (EHR) project, OnBase already has made physicians more efficient, allowing each physician to see approximately three more patients on a daily basis. OnBase gives physicians access to the most up-to-date medical records and supporting documentation making patient information such as medication requirements or previous illnesses more accurate and physicians more effective.

Because the implementation date was set with a strict deadline of March 30, 2008, SSM had to find a solution that was both flexible and scalable. With OnBase’s capability to be implemented in phases while also integrating with EPIC, Microsoft(R) SharePoint(R) and SAP(R), SSM was able to reach the deadline while staying within budget.

“We saw a need for a system to grow and scale with us while also being able to move outside of scope of the electronic health record,” related Chris Bullerdick, IT Director at SSM Health Care. “As a partnership, Hyland Software worked with us to go-live with OnBase in 45 days in the first hospital and will eventually scale OnBase across more than 5,000 physicians in our system.”

Bullerdick continued saying, “With such a variety of users within our 25,000 plus employees, the integrations with SharePoint and SAP make OnBase the complete solution for our ultimate goal of accomplishing patient safety.”

“SSM is a prime example of a healthcare system that understands the importance of technology as it relates to patient care and quality,” according to Tim Tegeder, Director of Healthcare Solutions at Hyland Software. “Our collaboration with SSM to create an integrated solution that also worked within the timetable of the EHR initiative has allowed the provider to increase their already strong focus on the patient.”

About SSM Health Care

SSM Health Care is sponsored by the Franciscan Sisters of Mary and based in St. Louis, Mo., and is one of the largest Catholic health systems in the country and the first health care recipient of the Malcolm Baldrige National Quality Award. The system owns, manages and is affiliated with 20 acute care hospitals and two nursing homes in four states: Missouri, Illinois, Wisconsin and Oklahoma. More than 5,000 affiliated physicians and 24,000 employees work together to provide a wide range of services that are compassionate, holistic and of high quality. For more information, please visit http://www.ssmhc.com/ .

About Hyland Software Healthcare Solutions

Hyland Software Inc. is the developer of OnBase, a rapidly deployable suite of enterprise content management (ECM) software applications. Deployable as a premises-based solution or via software as a service (SaaS), OnBase is a modular suite of ECM applications that includes document imaging, workflow, electronic document management, COLD/ERM and records management. OnBase Healthcare Solutions enable organizations to run more efficiently by managing content and streamlining workflows across the enterprise with point solutions for revenue cycle management, medical records and back office operations. For more information about OnBase, an AHA endorsed solution, please contact an Authorized OnBase Solution Provider or visit http://www.onbase.com/ .

   Contact:   Kaitlin Maurer   Public Relations Manager   Hyland Software   (440) 788-6833   [email protected]  

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20070110/CLW019LOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, [email protected]

Hyland Software Inc.

CONTACT: Kaitlin Maurer, Public Relations Manager of Hyland Software,+1-440-788-6833, [email protected]

Web site: http://www.onbase.com/http://www.ssmhc.com/

TORONTO, July 9 /PRNewswire-FirstCall/ — Lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) (“Lorus” or the “Corporation”), a biopharmaceutical company specializing in the research and development of pharmaceutical products and technologies for the management of cancer, today announced progress made in the Virulizin(R) development program, including the publication of two research studies on the Virulizin(R) mode of action and the issuance of a new patent for Virulizin(R) in Mexico.

“Publication of these two studies in international scientific journals adds significantly to our previous studies on Virulizin(R) anticancer mechanisms and activities,” commented Dr. Aiping Young, Lorus’ President and CEO. “In addition, allowance of a new patent strengthens the intellectual property position for this product, and protects the potential for expanding the use to other cancer indications in this jurisdiction.”

New Virulizin(R) patent issued in Mexico

The patent, titled “Immunomodulating Compositions from Bile for the Treatment of Immune System Disorders”, protects methods of treating several cancers using Virulizin(R). This is the second patent issued in Mexico for Virulizin(R), and extends patent protection for Virulizin(R) in this country to 2016. Similar patents for Virulizin(R) have also been issued in a number of other countries worldwide, including Canada, Australia, and the United States.

Virulizin(R) is currently approved for the treatment of malignant melanoma in Mexico. The new patent provides protection for the potential treatment with Virulizin(R) of additional cancers, including ovarian and lung cancers. Virulizin(R) composition, manufacturing process, and use in the treatment of cancers are also protected in Mexico under an earlier patent issued to Lorus in 2003.

Virulizin(R) has demonstrated significant anticancer activity against a wide range of human cancers in preclinical studies, and has been tested in several clinical trials in solid tumor indications, including a Phase III clinical trial in combination with gemcitabine in locally advanced and metastatic pancreatic cancer. Lorus has reported that the overall survival data in this Phase III study did not reach statistical significance, although exploratory analysis yielded promising results in specific patient populations including in patients with ECOG performance status of 0 or 1.

In April 2008, Lorus’ subsidiary GeneSense Technologies entered into an exclusive multinational license agreement for Virulizin(R) with Zor Pharmaceuticals LLC to further develop and commercialize Virulizin(R) for advanced pancreatic cancer and other therapy areas in North and South America, Europe, and Israel.

Virulizin(R) study leads to new drug candidate IL-17E

The article entitled “Virulizin(R) induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors” was published online in the journal Cancer Immunology Immunotherapy and is available through PubMed (http://www.ncbi.nlm.nih.gov/PubMed/).

The study showed that Virulizin(R) treatment stimulates the immune system to produce the cytokine IL-17E, which in turn triggers an anticancer effect through activation and tumor recruitment of eosinophils. This novel aspect of the anticancer mechanism of action for Virulizin(R) adds to previous studies showing that Virulizin(R) activates other cells of the immune system, including macrophages and Natural Killer (NK) cells.

A key finding of this report was that IL-17E itself had significant anticancer activity when used in mouse models of human cancers. Preliminary studies have revealed that IL-17E has potent activity against several human tumor types, including colon cancer, melanoma, and pancreatic cancer, with low toxicity. Lorus has patent applications pending in major markets, including Canada, Europe and the United States, to protect the use of IL-17E in the treatment of these cancers, both alone and in combination with other chemotherapies.

Virulizin(R) stimulates production of the antitumor protein TNFalpha

The article titled “Virulizin(R), a novel immunotherapy agent, stimulates TNFalpha expression in monocytes/macrophages in vitro and in vivo.” was published in the journal International Immunopharmacology (volume 7, issue 10, pages 1350-9).

The study revealed that treatment with Virulizin(R) resulted in a significant induction of the cytokine TNFalpha in tumors in a mouse model of malignant melanoma. Virulizin(R) also stimulated production of TNFalpha in human macrophages in vitro. Importantly, a direct relationship between TNFalpha production by Virulizin(R) and cytotoxic activity towards cancer cells was demonstrated.

TNFalpha is a protein that is produced by cells of the immune system, particularly macrophages, which then activate other immune cells to attack tumor cells. The anticancer properties of TNFalpha are well known, and have been studied in both preclinical and clinical settings. These new findings confirm initial studies indicating that TNFalpha can contribute to the antitumor mechanism of Virulizin(R).

About Virulizin(R)

Virulizin(R) is a novel biological response modifier (or immunotherapeutic agent) that stimulates a patient’s immune system through several mechanisms, including the activation of macrophages and the infiltration of natural killer cells into tumors. In preclinical studies, Virulizin(R) has demonstrated potential high levels of antitumor activity against a number of cancer indications including pancreatic cancer. Virulizin(R) has been granted orphan drug status and fast track status from the United States FDA and orphan designation from the Marketing Authorization Application with the European Medical Evaluation Agency (EMEA). A drug that receives fast track designation must demonstrate that it is intended for the treatment of a serious or life-threatening condition and that it has the potential to address unmet medical needs for the condition. Virulizin(R) is a registered trademark owned by Lorus Therapeutics Inc.

About Lorus

Lorus is a biopharmaceutical company focused on the research and development of novel therapeutics in cancer. Lorus’ goal is to capitalize on its research, preclinical, clinical and regulatory expertise by developing new drug candidates that can be used, either alone, or in combination with other drugs, to successfully manage cancer. Through its own discovery efforts and an acquisition and in-licensing program, Lorus is building a portfolio of promising anticancer drugs. Lorus Therapeutics Inc. is listed on the Toronto Stock Exchange under the symbol LOR, and on the American Stock Exchange under the symbol LRP.

Forward-Looking Statements

This press release may contain forward-looking statements within the meaning of Canadian and U.S. securities laws. Such statements include, but are not limited to, statements relating to: our research program plans, our plans to conduct clinical trials, the successful and timely completion of clinical studies and the regulatory approval process, our ability to fund future research, our plans to obtain partners to assist in the further development of our product candidates, the establishment of corporate alliances, the Company’s plans, objectives, expectations and intentions and other statements including words such as “continue”, “believe”, “plan”, “expect”, “intend”, “will”, “should”, “may”, and other similar expressions. Such statements reflect our current views with respect to future events and are subject to risks and uncertainties and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by us are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors could cause our actual results, performance or achievements to be materially different from any future results, performance, or achievements that may be expressed or implied by such forward-looking statements, including, among others: our ability to obtain the capital required for research and operations, the inherent risks in early stage drug development including demonstrating efficacy, development time/cost and the regulatory approval process; the progress of our clinical trials; our ability to find and enter into agreements with potential partners; our ability to attract and retain key personnel; changing market conditions; and other risks detailed from time-to-time in our ongoing quarterly filings, annual information forms, annual reports and annual filings with Canadian securities regulators and the United States Securities and Exchange Commission.

Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled “Risk Factors” in our Annual Information Form underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and we do not intend, and do not assume any obligation, to update these forward-looking statements, except as required by law. We cannot assure you that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Investors are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.

Lorus Therapeutics Inc.’s recent press releases are available through the Company’s website at http://www.lorusthera.com/. For Lorus’ regulatory filings on SEDAR, please go to http://www.sedar.com/. For SEDAR filings prior to July 10, 2007 you will find these under the company profile for Global Summit Real Estate Inc. (Old Lorus).

Lorus Therapeutics Inc.

CONTACT: Lorus Therapeutics Inc., Dr. Saeid Babaei, (416) 798-1200 ext.490, [email protected]

Pro-Pharmaceuticals, Inc. (AMEX: PRW), a bio-pharmaceutical company developing proprietary polysaccharide-based therapeutic compounds for the treatment of cancer and fibrosis, has entered into an agency agreement with Sanghyon Chemical to represent the Company with major pharmaceutical companies in Korea. Sanghyon Chemical will provide for the registration of DAVANAT(R) with the Korean FDA and marketing and sales support for the licensing and distribution of DAVANAT(R) to treat cancer with chemotherapy drugs.

“The collaboration with Sanghyon Chemical is another step in the realization of commercializing DAVANAT(R) on a regional basis,” said Theodore Zucconi, Ph.D., President of Pro-Pharmaceuticals. “We continue to pursue partnerships with regional distributors who understand how to do business in their regions, as well as with several large international pharmaceutical companies. Sanghyon is an experienced partner that will enable us to penetrate a major market such as Korea.”

Sanghyon Chemical specializes in pharmaceutical specialties and raw materials. Sanghyon imports raw materials to Korea from companies such as Bristol-Myers Squibb (NYSE: BMY) in the U.S. and Cognis in Australia. Sanghyon has business relationships with the “Top Ten” Korean companies such as LG Life Sciences, Dong-A, Yuhan, Daewoong Pharmaceutical Company, SK Chemicals and Hanmi Pharmaceutical Company Ltd.

“We will bring partners to Pro-Pharmaceuticals who are interested in licensing DAVANAT(R) for use with Irinotecan, 5-FU and other chemotherapy drugs. The antineoplastic market in Korea is more than $600 million per year and growing at about 25% annually. Korea represents a great opportunity for Pro-Pharmaceuticals and we are happy to represent them,” said Mr. Y.J. Kim, Sales Manager for Sanghyon Chemical Corp.

About DAVANAT(R)

DAVANAT(R) is a proprietary carbohydrate polymer that is administered with chemotherapies and biologics to treat cancer. DAVANAT(R)’s mechanism of action is based on binding to lectins. DAVANAT(R) targets specific lectin receptors (“Galectins”) on cancer cells. Current research indicates that Galectins affect cell development and play important roles in cancer, including tumor cell survival, angiogenesis and tumor metastasis.

Pro-Pharmaceuticals, Inc. – Advancing Drugs Through Glycoscience(R)

Pro-Pharmaceuticals is engaged in the discovery, development, and commercialization of carbohydrate-based, targeted therapeutics for advanced treatment of cancer, liver, microbial, and inflammatory diseases. Initially, the product pipeline is focused on developing targeted therapeutic compounds to treat cancer. The Company’s technology also is being used to treat liver and kidney fibrosis. The Company is headquartered in Newton, Mass. Additional information is available at www.pro-pharmaceuticals.com.

Pro-Pharmaceuticals, Inc. – Advancing Drugs Through Glycoscience(R)

Pro-Pharmaceuticals is a clinical stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based, target therapeutic compounds for advanced treatment of cancer, liver, microbial and inflammatory diseases. The Company’s initial focus is the development of carbohydrate polymers to treat cancer patients. DAVANAT(R), the Company’s lead product candidate, is a polysaccharide polymer that is in Phase II trials for colorectal and biliary cancer. The Company’s technology is also being used to develop new chemical entities to treat liver and kidney fibrosis. The Company is headquartered in Newton, Mass. Additional information is available at www.pro-pharmaceuticals.com.

DAVANAT(R) and Advancing Drugs Through Glycoscience are registered trademarks of Pro-Pharmaceuticals.

FORWARD LOOKING STATEMENTS: Any statements in this news release about this or future financings, expectations, plans and prospects for the Company, including without limitation, statements containing the words “believes,””anticipates,””plans,””expects,” and similar expressions, constitute forward-looking statements as defined in the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements regarding the expected closing of the private placement and the anticipated use of proceeds. These forward-looking statements are based on management’s current expectations and are subject to a number of factors and uncertainties, which could cause actual results to differ materially from those, described in such statements. More information about those risks and uncertainties is contained in the Company’s quarterly or annual report, Form 8-K and in the Company’s other reports filed with the Securities and Exchange Commission. While the Company anticipates that subsequent events may cause the Company’s views to change, the Company disclaims any obligation to update such forward-looking statements.

BETHESDA, Md., July 9 /PRNewswire/ — leViv, Inc. (http://www.leviv.com/), the only company focused exclusively on nutrition and lifestyle programs for individual health, has launched five innovative programs today. The new programs include 28-days of delicious, delivered food (2 meals and 2 snacks per day — over 110 items in every order), online recipes, health strategies, online communities, educational resources, professional advice, news, health information and more.

“The idea was born from a real problem; helping my parents sort through all of the confusing nutrition and lifestyle information in the market today. They asked, ‘Should we eat tomatoes? Drink red wine? Eat high fat or low carb? Eat meat or avoid meat? Take flax or avoid wheat?'” said CEO and founder, Mitchell Goldsteen. “Given the lack of quality options actually focused on health and not simply fad weight loss, we decided it was time to create a significantly different and significantly better option.”

“We believe our consumers want change. They want to feel better. They demand and deserve quality. Our product is healthier than any other program, has more natural antioxidants, uses better ingredients and is more affordable than other programs. We are working hard to create a new brand — a brand driven by our passion, our skills, the best available information and a healthy dose of sleepless nights,” said Goldsteen. leViv offers the first comprehensive programs that are designed to provide adults concerned with type II diabetes, cardiovascular disease, chronic kidney disease, and prostate cancer with a convenient, nutritious, and delicious monthly program that aims to affordably improve health. leViv programs are also perfect for all adults looking to live healthfully. While weight loss is not leViv’s primary objective, it is an added benefit of leViv’s balanced and unique approach.

leViv programs deliver exceptional taste with superior nutrition. Benefits of targeted nutrition and lifestyle can include: increased energy, balanced blood sugar, lowering of bad cholesterol, increasing of good cholesterol, endothelial health, strengthening organ function and more. leViv, along with many in the medical community, understand the powerful synergy between nutritious foods, traditional medicine and an active lifestyle. leViv regularly incorporates emerging scientific benefits associated with antioxidants, phytonutrients, plant based proteins, cruciferous vegetables, omega-3 fatty acid, isoflavones and more.

So what’s on the menu? Wild caught salmon, pizza, jerk chicken, black cod, lasagna, and so much more. “Great taste is paramount to enjoying your meals and wanting to continue with any nutrition or lifestyle program,” said Jayson Grossberg, leViv Managing Director and Global Head of Culinary. “We do not disappoint. But what excites us is our healthful way of achieving great flavors. Our sodium levels are lower than any existing commercial program, our saturated fat and cholesterol levels are ideal and we work diligently to avoid artificial sweeteners or chemicals; just whole foods and love.” To deliver value, we sell and ship directly to our customers and chose to invest in the quality of our ingredients. leViv products can only be ordered online at http://www.leviv.com/ or call 1.888.99.leViv.

About leViv

leViv, Inc., founded in 2007, is a leading consumer health company based in Bethesda, Maryland. Our objective is to improve the health of the widest number of people possible. As a Company, we believe in being socially responsible, honest and devoted to improving our community. We have developed the first comprehensive online and offline platform for consumers to focus on health through nutrition and lifestyle.

   leViv currently focuses on five key areas:   -- healthy living   -- cardiovascular health   -- type II diabetes   -- men's health   -- kidney health  

leViv, Inc.

CONTACT: leViv, Inc., 1-888-99-leViv, [email protected]

Web site: http://www.leviv.com/

By Tom Kisken, Ventura County Star, Calif.

Pain patients understand why California’s attorney general says he needs to raise $3.5 million to stop addicts and drug dealers who use doctors to stockpile Vicodin and OxyContin.

Abuse of prescription medicine is rampant in part because chronic pain can put your head in a vise and reduce you to a lump of flesh unable to do anything but lie on a sofa, said Bob Ramos of Santa Paula, whose spine has been surgically fused. It can feel as if “someone was grabbing your ligaments and pulling them out of your back,” said Terry Kierzek of Agoura Hills, who had a cyst on his spine.

Largely misunderstood and, according to some experts, neglected by the healthcare community, pain can drive dependence on prescription drugs. The medication is highly addictive, doesn’t address the source of pain but clouds the sear and throb that, as Mary Schirm of Thousand Oaks put it, “will drive a person insane.”

“Do I understand the need for medication? The need to stockpile? The need to gather drugs? Absolutely, 100 percent,” said Schirm, who has massive headaches but fights the temptation to overmedicate.

Edmund G. Brown Jr., the former governor and presidential candidate who is now California’s top cop, wants to implement an online database that would track prescriptions for addictive drugs. While a patient waited, pharmacies and doctors could check the database and make sure the person isn’t doctor-shopping — collecting a half-dozen prescriptions from different doctors for painkillers.

“The motive is to allow doctors not to unwittingly overprescribe, or if they illegally do it, we want to go after them,” said Brown, who hopes to implement the system next year if partner groups can raise the money.

The magnitude of the problem is hard to diagnose, though state officials cite a 2007 report from the Coalition Against Insurance Fraud. It suggests insurance companies are billed nearly $73 billion a year for prescription drugs that are abused or resold.

Ventura County prosecutors filed charges Tuesday against Dr. Bernard Bass of North Hollywood for allegedly conspiring to provide patients with OxyContin and hydrocodone after surrendering his license to prescribe. Prosecutors say they’re investigating the possibility of a connection between Bass’ prescriptions and the deaths of six of his patients from Ventura County.

‘A problem like any other drug is’

Dr. Michael Huff, an Oxnard pain specialist and once the president of the Ventura County Medical Association, was charged in 2003 with 55 counts of illegal distribution in a case ignited by overdose deaths involving OxyContin. Huff pleaded guilty to one count in 2006 and was sentenced to more than three years in prison.

“It’s a problem like any other drug is,” said sheriff’s narcotics Detective Victor Fazio. “We’re looking at the abuse and the illicit use and resale of prescription drugs just the same as we look at cocaine, methamphetamine and marijuana.”

Fazio said he believes doctors are conned by as many as 10 percent of their pain patients into providing unneeded drugs. Because the doctors can’t measure pain, they take patients at their word.

“Any good doctor is going to get duped a fair percentage of time,” he said. “It’s when they have a blind indifference to what’s going on in their practice and they become known as a source of supply for drug dealers in the street, that’s when we get involved.”

Dr. Kamyar Assil, a specialist in Thousand Oaks, said pain care focuses on much more than medication and includes procedures aimed directly at the source of pain.

When Assil does prescribe painkillers, he demands his patients sign a contract agreeing to get medication only from one doctor and one pharmacy. He said very few people challenge that system. But a year ago, Assil called deputies to his waiting room to confront a patient believed to be forging prescriptions for Vicodin.

Not everybody is as vigilant.

“We know there are certain doctors who tend to collect patients who pay cash and get huge prescriptions of OxyContin, etc.,” Assil said. “Just in our area, within a 20- to 30-mile radius in the last eight or nine years, two or three doctors have lost their licenses.”

Dr. William Coburn of Thousand Oaks surrendered his license after being arrested three years ago on suspicion of trading Xanax and Norco for a gun. Prosecutors dropped the narcotics accusation, and Coburn pleaded no contest to two misdemeanor weapon counts.

Pain specialists say the arrests have a numbing effect on primary care doctors.

“I think that kind of shook everybody,” said Dr. Estela Diesfeld of Ventura, referring to Huff. “Immediately, you saw a lot of doctors refusing to write any (addictive) pain relievers or any tranquilizers.”

The reluctance mirrors a societal misunderstanding of pain management, said U.S. Rep. Lois Capps, D-Santa Barbara. The registered nurse is co-sponsoring a pain care bill aimed at increasing research, community education and training of healthcare professionals.

People don’t understand their pain can be treated by therapy and other procedures, Capps said. They stockpile drugs because they don’t see any alternatives.

“Prescription drug fraud comes from a lack of good healthcare,” she said.

When the pain in his head and neck is at its radiating worst, Bob Ramos can’t do anything except rest or take the Vicodin that is used only for what he calls breakthrough attacks. He’s had three neck surgeries and traces his pain to high school football and a car crash when he was 22.

Brown’s plan praised

Like many pain patients, he worries about becoming too reliant on pain medication and no longer takes OxyContin because it’s too addictive. He praised Brown’s plan for an online prescription database.

“I think that’s great because there’s abuse out there,” he said, thinking of the people who do whatever they can to get painkillers. “You’re playing with a loaded gun.”

The state’s database already exists, made from mandatory prescription reports filed by doctors and pharmacies. But when doctors currently make requests for information, it can take three weeks to get a response, meaning the information is of little value.

An online system that provides instant access would give doctors and pharmacies more control, said Dr. Scott Fishman, a medical school professor at UC Davis and president of the American Pain Foundation. It would empower doctors to prescribe drugs without worrying about being duped.

Diesfeld of Ventura worries the database may have gaps, meaning doctors and pharmacies could still make mistakes. Fishman worries doctors could see the plan as an attempt by law enforcement to catch doctors who make a mistake.

Brown brusquely rejects the criticism, worrying only about the money needed to create the system. The state’s $15 billion deficit means the $3.5 million will have to come from outside sources. That fundraising drive is being led by the Troy and Alana Pack Foundation, named for children killed by a driver who was using prescription medication that came from multiple doctors.

The attorney general sees the database as a way to make prescriptions transparent. “This to me is a no-brainer,” he said, “and if there are abuses, we will crack down on them.”

By Lisa Rosetta, The Salt Lake Tribune

Jul. 9–It is unknown how many women in Tanzania have breast cancer.

That’s because some of them may be dying of the disease and don’t know it.

While many women in the United States regularly get mammograms — with the hope of catching breast cancer early — Tanzanian women get the low-dose X-rays only after they’ve been diagnosed or have suspicious lumps.

A Salt Lake City doctor who is headed to the east African country this week hopes to change that.

Brett Parkinson, imaging director of breast-care services at Intermountain Medical Center’s breast-care center, will travel to Dar es Salaam on Friday. He and Dianne Kane, nursing director for oncology services, will help start Tanzania’s first breast cancer screening program.

Right now, there is only one functional mammography machine in the entire country, Parkinson said. Breast cancer is the third most common cancer among women there, accounting for 9.3 percent of all cancer seen at the Ocean Road Cancer Institute in Dar es Salaam, according to the Medical Women Association of Tanzania.

About 80 percent of those cases are diagnosed when the cancer is in an advanced stage and not curable. In such cases, the only treatment available in Tanzania is complete removal of the breast — an option many women decline.

“We hope to take the many opportunities we have in the U.S. and share them with our colleagues and with the women of Tanzania — that’s the reason we’re going,” Parkinson said.

The Salt Lake City team’s first goal is to improve screening. By the end of the summer, he said, there will be 10 mammography machines up and running in Tanzania — plus five ultrasound machines, donated by companies Hologic Inc. and Alliance Imaging.

Donations of film, cassettes and other items have also been sent to Tanzania, coordinated by Salt Lake City-based Globus International Relief.

During Parkinson and Kane’s 10-day trip, they’ll teach doctors and technologists how to read mammograms, operate the machines and set up practices for follow-up care. One group of seven Tanzanian doctors have a head start: they visited Salt Lake City in June for about a week’s worth of training on how to read mammograms.

“We tried to show them a spectrum of what they might see there,” he said.

Parkinson and Kane, officers of the East African Breast Care Project, will make subsequent trips to teach surgeons different techniques — such as a lumpectomy — for removing cancer while sparing women’s breasts.

The project began about two years ago, after Southern California trial lawyer James Parkinson — Parkinson’s brother — read about a 39-year-old Tanzanian woman’s losing battle with the disease. James Parkinson is now co-chairman with Mississippi businessman and attorney Wil Colom.

With 10 mammography machines, Parkinson said, about 250 women could be screened a day — just a fraction of those women who need one. But it’s a start, he said.

“Our goal is to not only establish a screening program in Tanzania, but if the need arises — and we’re asked to do more — we’d be happy to take this to other nations in Africa,” he said. “We’re so fortunate in the U.S. to have these resources, it’s incumbent upon us in the United States to share.”

[email protected]

—–

To see more of The Salt Lake Tribune, or to subscribe to the newspaper, go to http://www.sltrib.com.

Copyright (c) 2008, The Salt Lake Tribune

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

NASDAQ-NMS:HOLX, NYSE:AIQ,

By Dick Youngblood, Star Tribune, Minneapolis

Jul. 9–In 25 years as a hospital administrator, pharmacy chain executive and founder of a hospital pharmacy business, Lewis Zeidner saw dozens of small, independent drugstores close or be snapped up by national chains as their owners reached retirement age.

He thought there might be a better way. So he set out two years ago to offer retiring pharmacy owners an alternative to selling out to the big chains.

Zeidner’s answer: another drugstore chain.

He and business partner James Cox are founders of ApothecaryRx, a Golden Valley company that has acquired 18 independent drugstores in five states since mid-2006 as the foundation for what Zeidner calls “the anti-chain chain.”

Translation: Their aim is to capitalize on the efficiencies of a chain operation while retaining the features and community loyalty behind successful independent pharmacies, which they pledge will continue to operate autonomously.

The score so far: ApothecaryRx grossed $40.7 million in 2007, a year that started with five stores and ended with 10. The net before interest and taxes was $763,000.

And with 14 stores on board by the end of the first quarter, the company posted nearly $16 million of sales and a $597,000 pretax net in the first three months of 2008.

The stores acquired in 11 transactions so far are in Illinois, Oklahoma, Colorado, Missouri and Minnesota, including two stores apiece in Red Wing and St. Cloud plus one in Wayzata.

Zeidner figures that’s just the beginning.

“In 2007, the National Association of Chain Drugstores estimated that owners of about 2,000 independent drugstores were nearing retirement age,” said Zeidner, 52, the company’s president and CEO. Backed by bank financing underwritten by a private investor, he figures to latch onto a significant share of those prospects.

The strategy is to acquire already successful stores with above-average revenues of at least $5 million, a level that Zeidner calls “a sign of success and a signal that the community values it.”

The plan is to keep the stores’ names, signage, merchandising and personal service policies, including such perks as charge accounts and free deliveries. And because customer relationships are regarded as essential, personnel and their wages and benefits also will remain the same, Zeidner said.

“I believe in the service model of the independent pharmacies, where they know their customers, talk to their customers and educate their customers,” he said.

Yet having labored as CEO of a company that managed hospital pharmacies in 35 states, he’s also aware of the financial savings inherent in a larger organization.

Volume discounts on inventory are a significant plus, and so is a standardized computer system that promotes more efficient work flow. Most of the acquired stores did not have state-of-the-art systems, said Cox, 36, the company’s vice president of operations.

In tandem with the updated computer system, a standardized accounting system offers the opportunity “to watch the business on a daily basis, so we can react more quickly to problems and opportunities,” Cox said.

A company-wide benefits plan also provides savings on volume, Zeidner said, adding that the benefits “are at least as good as before the acquisitions, if not better.”

Altogether, the changes have improved the bottom line by about 1.5 percent so far, he said.

Zeidner and Cox also have added services aimed at boosting sales and cementing customer loyalty. For example: Because some diabetics, mainly older ones, require special fittings and inserts for their shoes, they opened small shoe departments in nine of the stores so far and are working on adding them to the remaining stores soon.

And when they realized that many customers were forgetting to refill their prescriptions on time, they added an application that alerts pharmacists to phone a reminder to the patient. The same process also tracks prescriptions that are switched to other pharmacies, so a query letter can be made to identify any problems that might have triggered the change.

Trained as a clinical psychologist, Zeidner spent his career in the health-care field. Before starting ApothecaryRx, he was a co-founder of PrairieStone Pharmacy, which operated pharmacies in Lunds and Byerly’s stores. That’s where he met Cox, a veteran pharmacist who wound up as PrairieStone’s director of operations.

They started the company with $17.5 million in bank loans backed by an Oklahoma businessman who has become a majority shareholder in ApothecaryRx. The credit line subsequently was expanded to $45 million, of which $17.2 million has been spent.

Zeidner said he expects two more stores to be added in August, with three more targeted for acquisition by year-end.

Dick Youngblood –612-673-4439

—–

To see more of the Star Tribune, or to subscribe to the newspaper, go to http://www.startribune.com/.

Copyright (c) 2008, Star Tribune, Minneapolis

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

Cummins Inc.

Blair Claflin, 317-610-2542

Global Diversity Communications Manager

OR

Eli Lilly and Co.

Christopher J. Banguis, 317-277-6726

Senior Associate

Six Sigma Communications

Global Diversity

Logo: http://www.cummins.com

Cummins Inc. (NYSE: CMI) and Eli Lilly and Co., two of Indiana’s largest corporations, are joining forces to help minority-owned businesses at Indiana Black Expo’s Summer Celebration.

The two companies are sponsoring a workshop July 15 on Six Sigma, the business problem-solving technique credited with saving corporations millions of dollars annually, as part of the Black Business Conference at the 38th annual event in Indianapolis.

“Lilly has successfully used Six Sigma for more than three years,” said Liz Klimes, Vice President of Six Sigma for the pharmaceutical company. “We’re pleased to have an opportunity to share our expertise and experience with local businesses.”

“Companies that undertake this training will see increased opportunities not only as a supplier to Cummins but as a supplier to any number of other leading corporations,” said Gordon F. Fykes, Director of Diversity Procurement for Cummins, which produces diesel engines and related technology as well as power generation systems.

Six Sigma seeks to reduce waste and variability through a data- driven analysis that allows businesses to identify the crux of a problem free of distortions and distractions that might be obscuring a solution.

Lilly and Cummins have been using the technique for several years but it is not as widely used by small businesses.

“Six Sigma is not easy for any company to embrace regardless of size,” said George Strodtbeck, Cummins’ Executive Director of Corporate Quality and Cummins Operating System and an expert on the business problem-solving technique. “But it works for any organization willing to devote the appropriate energy necessary to make broad-based change.”

The workshop will include an overview of Six Sigma from 2 to 4 p.m. followed by a panel discussion from 4 to 6 p.m. that will include minority and women-owned business leaders who have used the technique successfully.

The 38th annual Indiana Black Expo Summer Celebration runs from July 10 to July 20 in Indianapolis.

Here are some other Cummins events at Summer Celebration:

— Professional Networking and Business Card Exchange

Minority business owners can ask questions of leaders from top companies across Indiana and the nation at this networking event sponsored by Cummins, Allstate, United Water and Hunt Construction.

When: 6 p.m. – 9 p.m. July 15, Indiana Convention Center, Wabash Ballroom 1 and 2

— NMMI Workshop

National Minority Manufacturing Institute (NMMI) Founder and CEO David J. Burton will teach participants how to develop key performance indicators so they can evaluate such things as supply chain performance.

When: 9 – 11 a.m., July 16, 2008, Indiana Convention Center, Room 201.

— Employment Opportunity Fair

Cummins is a co-sponsor of the Employment Opportunity Fair at the Indiana Black Expo’s Summer Celebration, providing visitors with information about jobs at the Company as well as help with resumes and much more.

When: 9 a.m. – 7 p.m., July 17, Indiana Convention Center, 500 Ballroom.

— Consumer Booth Exhibitor Fair

Visitors will be able to learn more about the Company and its products and the Consumer Booth Exhibitor Fair at the Indiana Convention Center’s Exhibit Hall.

When: noon to 9 p.m., July 18; 10 a.m. – 10 p.m., July 19; noon to 6 p.m., July 20.

About Cummins

Cummins Inc., a global power leader, is a corporation of complementary business units that design, manufacture, distribute and service engines and related technologies, including fuel systems, controls, air handling, filtration, emission solutions and electrical power generation systems. Headquartered in Columbus, Indiana, (USA) Cummins serves customers in approximately 190 countries and territories through a network of more than 500 company- owned and independent distributor locations and approximately 5,200 dealer locations. Cummins reported net income of $739 million on sales of $13.05 billion in 2007. Press releases can be found on the Web at www.cummins.com.

Forward-Looking Disclosure Statement

Information provided in this release that is not purely historical are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the company’s expectations, hopes, beliefs and intentions on strategies regarding the future. It is important to note that the company’s actual future results could differ materially from those projected in such forward-looking statements because of a number of factors, including, but not limited to, general economic, business and financing conditions, labor relations, governmental action, competitor pricing activity, expense volatility and other risks detailed from time to time in Cummins Securities and Exchange Commission filings.

TABLE

Here are the workshop details:

Time:_ 2 – 6 p.m.

Date:_ July 15, 2008.

Place: Indiana Convention Center, Room 201.

(c) 2008 BUSINESS WIRE. Provided by ProQuest Information and Learning. All rights Reserved.

By Rusty Marks

Staff writer

Kanawha County emergency service officials accuse an Ohio-based ambulance company of “masquerading as an emergency ambulance service” and intentionally misleading the public about their credentials, according to documents sent to the state Office of Emergency Services.

Joe Lynch, executive director of the Kanawha County Emergency Ambulance Authority, said crews from Ohio-based Life Ambulance are trying to beat county ambulances to the scene of accidents to take victims to local hospitals.

Ambulance rides cost hundreds of dollars.

“It’s purely about money,” Lynch said Monday. “It’s to the point where it’s confusing the public, and it’s circumventing the 911 system. We’re concerned it’s going to affect the quality of care that the public deserves.”

Kanawha County Commission President Kent Carper said Life Ambulance is not authorized to provide emergency transportation in Kanawha County. Only the Kanawha County Emergency Ambulance Authority and the Charleston Fire Department are authorized to respond to emergencies, he said.

“The law allows us to dictate who makes emergency calls in the county, and they aren’t it,” Carper said. “We do this for a reason.”

Ordinarily, having an ambulance show up at the scene of an accident is a good thing, Lynch said. But he said county officials are worried about Life Ambulance’s employee training and the state of their equipment.

In response to a Freedom of Information Act request filed with the Ohio Medical Transportation Board, Lynch discovered that Life Ambulance has been fined $30,000 since 2005 and received five complaints in Ohio, including operating an unpermitted ambulance, drivers operating without proper training and complaints about the condition of Life Ambulance vehicles or equipment.

County officials believe Life Ambulance crews are listening to police scanners to find out about accidents, then sending ambulances without being dispatched by local 911 dispatchers. According to information sent to the state Office of Emergency Services, Life Ambulance sent six vehicles to one recent accident.

Lynch said staff at local hospitals have also complained about Life Ambulance crews attempting to muscle their way into the hospital or hijack patients. More importantly, he said, hospital staff have complained about Life Ambulance crews bringing in patients who should have received emergency care before being put in the ambulance.

Gene Meadows, general counsel at Life Ambulance’s headquarters in Portsmouth, Ohio, said Life Ambulance crews aren’t listening to police scanners in an attempt to hijack patients.

“We’ve got enough calls that are coming in,” he said.

But, he said, “With the number of ambulances we have on the road, we can’t help but come across [car crashes.]

“If there’s someone lying on the side of the road who needs assistance, we can’t help but stop and assist them.”

Contacted by cellular phone in a car on his way to Indiana, Meadows said he did not have access to company records on Monday.

He did not immediately know how many ambulances Life Ambulance operates in Kanawha County, how many employees the company has in the county or how much the company is paid to take an accident victim to the hospital.

Reach Rusty Marks at rusty [email protected] or 348-1215.

(c) 2008 Charleston Gazette, The. Provided by ProQuest Information and Learning. All rights Reserved.

LOS ANGELES, July 8 /PRNewswire/ — In response to media reports suggesting that Univision’s Fernando Del Rincon’s cancer diagnosis was fabricated in order to draw media attention to himself, PADRES CEO, Elvia Barboa, M.A., found it imperative to issue the following statement to dispel such potentially libelous remarks:

“PADRES’ responsibility is to ensure that accurate information is disseminated as it relates to the organization and its representatives. With respect to Fernando Del Rincon, the fact remains that he was diagnosed with bladder cancer in May 2008 and, fortunately, underwent a successful surgery that removed his tumor.”

The rumors have caused concern for PADRES in particular because Del Rincon serves as one of its national spokespersons. PADRES Contra El Cancer is an organization committed to improving the quality of life for Latino children with cancer and their families. Most importantly, PADRES served as an integral part in Del Rincon’s entire diagnosis and treatment.

According to Ms. Barboa, “PADRES supported Fernando with the same care, compassion and patient navigation provided to any family who has a child with cancer. PADRES helped Fernando understand his tests, diagnosis and treatment options; helped him secure a second opinion; helped him navigate the complex healthcare system; and most importantly, offered him much-needed emotional support. PADRES stood beside and continues to stand by him every step of the way.”

Ms. Barboa disclosed that Fernando’s choice to make public his diagnosis on May 31, 2008 at the PADRES’ 5K Charity Run/Walk in Los Angeles stemmed from three reasons: 1) to encourage others to have annual health exams to prevent any serious disease; 2) to instill strength and hope in families to fight tenaciously for their children undergoing cancer treatment; and 3) to announce he would author a book reflecting on his emotional experience and struggles during his cancer process.

“If media outlets print inaccurate and misleading information about Fernando Del Rincon’s cancer diagnosis, then such may indirectly discredit PADRES Contra El Cancer and its 23 years of advocacy on behalf of the pediatric cancer community. PADRES has been fortunate to work with many families and celebrities. Likewise, we are aware that often times the truth can unfortunately be distorted. PADRES remains honored and privileged to have Fernando Del Rincon serve as our spokesperson,” concluded Ms. Barboa.

About PADRES:

PADRES Contra El Cancer (PADRES) is an organization committed to improving the quality of life for Latino children with cancer and their families. PADRES programs, activities and services, while primarily oriented to the Latino community, serve childhood cancer patients from ALL races and ethnic origins. No family is turned away.

PADRES Contra El Cancer

CONTACT: Maribel De La Torre of PADRES Contra El Cancer, Cell,+1-818-581-5458, [email protected]

Web site: http://www.iamhope.org/

Huron Consulting Group Inc. (NASDAQ: HURN), a leading provider of financial and operational consulting services, today announced the acquisition of Stockamp & Associates, Inc., a nationally recognized management consulting firm specializing in helping high-performing hospitals and health systems optimize their financial and operational performance.

“Huron aims to become the best health and education consulting firm globally, serving the highest levels of healthcare companies and research institutions. Joining the Huron and Stockamp teams will create a real powerhouse by serving multiple segments of the industry, including major health systems, academic medical centers and community hospitals,” said Gary E. Holdren, chairman and chief executive officer, Huron Consulting Group. “The healthcare industry is growing at an unprecedented rate, and we are very excited about the opportunity to combine Stockamp’s forces with ours to help clients deal with the many challenges facing this vital segment of our economy.”

“Uniting Stockamp with Huron’s existing Health and Education Consulting business enhances our position as a premier healthcare and education services provider,” added Holdren. “The addition of Stockamp allows us to continue to expand our footprint in the hospital consulting space. In particular, academic medical centers will be a major target of our new combined Health and Education Consulting business.”

“Stockamp’s people are also excited about the synergies and opportunities that will come from the Huron and Stockamp combination,” said Paul A. Kohlheim, president, Stockamp & Associates. “Stockamp and Huron have very similar corporate cultures, and we believe that our people will quickly form a strong team that will provide unmatched services in the health and education consulting space to help our clients achieve their business objectives.”

“The breadth of our service offerings and the depth of experience in our combined healthcare practices should further solidify Huron’s leadership in providing consulting services to hospitals, health systems and academic medical centers,” said David Shade, vice president, Huron Consulting Group’s Healthcare practice. “Healthcare demographics in the next 30 years point to increased pressures and opportunities at hospitals and research organizations. We believe Huron is well positioned to help these institutions achieve their important societal mission.”

Under the terms of the agreement, Huron has acquired the assets of Stockamp & Associates for approximately $219 million, consisting of $169 million in cash and $50 million in stock, subject to adjustment. Additional purchase consideration will be payable if specific performance targets are met. In the 12 months ended March 31, 2008, Stockamp had cash basis revenues of approximately $94 million. On a GAAP basis, including after the amortization of intangibles, the acquisition is expected to be dilutive to Huron’s earnings per share in 2008 and accretive in 2009. Huron will provide 2008 guidance updates when it releases results for the second quarter of 2008.

Founded in 1990 and based in suburban Portland, OR, Stockamp & Associates’ consulting services around performance improvement, revenue cycle improvement, patient flow and capacity improvement and supporting information technology solutions. Stockamp has completed engagements for more than 80 hospitals and health systems during the past 18 years, including some of the largest and most prominent in the U.S. In 2007, the American Hospital Association (AHA) awarded an exclusive endorsement for Revenue Cycle and Inpatient Flow improvement services to Stockamp. In addition, KLAS Enterprises awarded Stockamp the 2007 and 2006 Best in KLAS Award for Revenue Cycle Consulting – Transformation.

In 2007, Huron was named No. 3 on Modern Healthcare’s list of Largest Healthcare Management Consulting Firms. Huron’s employees have worked on engagements for more than 80 of the top 100 research universities, more than 50 percent of the top teaching hospitals, six of the top 10 largest healthcare systems ranked by Modern Healthcare, and 13 of the top 25 managed care organizations ranked by Atlantic Information Services.

With the acquisition, Dale Stockamp, the founder of Stockamp & Associates, will join Huron as a consultant and assist with transition and integration matters. He will also assist with major client development opportunities. Paul Kohlheim, president of Stockamp, will join Huron as a vice president and report to David Shade, who will continue to lead Huron’s expanded Healthcare practice. In addition to the Stockamp employees who will join Huron, the following individuals will be managing directors with the Company: Shelly A. Anderson, James R. Dail, Douglas W. Fenstermaker, Andrew L. Grobmyer, John M. Hutchens, Norman W. Johnson, Jeffrey D. Jones, Annette E. Kirby, Bruce G. Lemon, Timothy P. Miller, Gregory P. Morgan, Steven J. Norris, Michael F. Puffe, and Kenneth M. Saitow.

In connection with this acquisition, Huron amended its credit agreement effective July 8, 2008. The amended credit agreement consists of a $220 million senior secured term loan and a $240 million senior secured revolving credit facility, both maturing in February 2012. On July 8, 2008, Huron borrowed $164 million under this credit agreement to fund the acquisition of Stockamp. The balance of the credit facility will remain available for future working capital requirements and other corporate purposes. Also in connection with the acquisition, Huron amended its 2006 agreement for the acquisition of Wellspring Partners LTD to modify the terms of the Wellspring earn-out related to the revenue cycle business. Consideration for the amendment consisted of $20 million of stock, subject to adjustment.

Webcast

The Company will host a webcast on Wednesday, July 9, 2008 at 9:30 a.m. Eastern Time (8:30 a.m. Central Time) to discuss the acquisition of Stockamp. The conference call is being webcast by Thomson and can be accessed at Huron Consulting Group’s website at www.huronconsultinggroup.com/webcasts.aspx. A replay will be available approximately two hours after the end of the webcast and for 90 days thereafter.

About Huron Consulting Group

Huron Consulting Group helps clients effectively address complex challenges that arise in litigation, disputes, investigations, regulatory compliance, procurement, financial distress, and other sources of significant conflict or change. The Company also helps clients deliver superior customer and capital market performance through integrated strategic, operational, and organizational change. Huron provides services to a wide variety of both financially sound and distressed organizations, including Fortune 500 companies, medium-sized businesses, leading academic institutions, healthcare organizations, and the law firms that represent these various organizations. Learn more at www.huronconsultinggroup.com.

Statements in this press release that are not historical in nature, including those concerning Huron Consulting Group’s current expectations about the Company’s future results are “forward-looking” statements as defined in Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by words such as “may,””should,””expects,””plans,””anticipates,””believes,””estimates,” or “continues.” These forward-looking statements reflect our current expectation about our future results, levels of activity, performance or achievements, including without limitation, that our business continues to grow at the current expectations with respect to, among other factors, utilization rates, billing rates, and number of revenue-generating professionals; that we are able to expand our service offerings; that we successfully integrate the businesses we acquire; and that existing market conditions, including those in the credit markets, do not change from current expectations. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Therefore, you should not place undue reliance on these forward-looking statements. Please see “Risk Factors” in our 2007 Annual Report on Form 10-K and in other documents we file with the Securities and Exchange Commission for a complete description of the material risks we face.

A LACK of consultant dermatologists at a Cheshire hospital has forced patients – some with suspected skin cancer – to travel to Merseyside for treatment.

Patients are being referred to St Helens and Knowsley Teaching Hospitals Trust for vital treatment because of the shortage.

The Trust stepped in at short notice to provide the services and treatment.

Last night, an NHS source said it is Warrington Hospital that is suffering from a shortage of consultants, but the hospital was unable to confirm this yesterday.

Ann Marr, chief executive of St Helens and Knowsley hospitals, said: “The support of our excellent dermatology team means patients with suspected cancer will not miss out on the vital treatment they require.”

A spokesman for the Trust added: “This will not compromise the standard of services our existing patients receive.”

The patients will receive treatment at Whiston Hospital’s dermatology department.

(c) 2008 Daily Post; Liverpool. Provided by ProQuest Information and Learning. All rights Reserved.

RESPIRATORY CARE

RESPIRATORY disease is a major health problem and is on the rise in the UK. It is the second biggest killer in the country, with one in five people dying from the disease. One person in every seven in the UK is affected by lung disease – approximately eight million people.

Although a major factor, lung disease is not simply smoking- related and other factors such as genetics, nutrition, social deprivation and air pollution all affect lung health.

In South Tyneside the respiratory team look after patients with a wide variety of respiratory conditions, including obstructive sleep apnea, tuberculosis and restrictive lung diseases. They also provide services for lung cancer as well as pneumonia and for chronic obstructive pulmonary diseases (COPD) such as emphysema, asthma and bronchitis.

Many cases are the result of occupational exposure to materials – a grim legacy left by the region’s industrial heritage.

With a commitment to providing the most efficient and effective system of care, the team offer waiting times of less than two weeks for new patients.

Looking ahead the team plan to set up a ‘one-stop shop’ for lung cancer referrals. Simply put, the hospital would be able to offer patients clinic consultation, a bronchoscopy and a CT scan in one day, streamlining the assessment process and reducing the anxiety patients can suffer during in the lead up to diagnosis and treatment. This will be a fantastic development much appreciated by patients and staff alike.

EMERGENCY CARE

NHS hospitals face a challenging and fast-changing environment and having excellent emergency services is central to effective acute hospital care.

Typically, the Accident and Emergency Department in South Tyneside sees around 52,000 patients each year and about 7,500 of these need admission to hospital.

As part of the hospital’s ongoing programme of modernisation and service development, work is under way to develop a new ‘Integrated Emergency Care Centre’ which will bring together all emergencies making sure that a combined team of professionals are available as the patient arrives at hospital to quickly assess, treat and make a decision about ongoing care.

This will be supported by the hospital’s diagnostic services.

The new purpose-built unit is being designed with patient privacy and service quality in mind and led by Dr Shaz Wahid, the facility will be clinically managed by a team of consultant acute physicians.

It is an exciting time for emergency services in South Tyneside and another example of looking to the future to make sure good quality care is always available.

CARE OF THE ELDERLY

IT’S natural for people to assume that their local hospital only provides hospital care.

Nothing could be further from the truth. In fact most of South Tyneside Foundation Trust’s patients don’t need to come into hospital and they are successfully cared for at home with hospital staff working in close partnership with the patient, their family and other agencies.

This is never more true than in the care of elderly people. Consultant geriatrician and medical director, Dr Alan Rodgers says rapid access to assessment and treatment with good community support is the key to high quality health care for older people.

He has for many years led a service which ensures that older people are supported to live at home for as long as possible while having the back up of the specialist hospital and community teams where needed.

This is particularly important in South Tyneside because 6,000 people are aged 80 and over.

In addition 36,000 people have a long-term illness, 6,700 people have diabetes and 8,000 people have chronic obstructive pulmonary disease. With just over 10% of the population acting as unpaid carers and 2.7% providing more than 50 hours of unpaid care per week, this partnership approach to care is vital.

South Tyneside Trust has four consultants who have a range of special interests.

Dr Rodgers has a special interest in Parkinson’s disease, osteoporosis, palliative care and orthopaedic rehabilitation.

Dr Jon Scott has a special interest in stroke disease. Dr Katia Liang has a special interest in falls and orthopaedic rehabilitation and Dr Becky Wiseman has a special interest in memory problems.

With very low waiting times and consultant clinics every day of the week, the service is based on a very flexible system to allow fast turn round and assessment.

GENERAL CARE

PATIENTS from all over North East England needing surgery for cancer of the stomach or gullet now go to Newcastle’s Royal Victoria Infirmary for their ops.

This centralised system of treatment, used for the past five years, is described as a hub and spoke operation, the RIV being the hub and the region’s healthcare providers, South Tyneside NHS Foundation Trust included, being the spokes.

South Tyneside’s Trust is unique, however.

Kamil Wynne is a consultant surgeon in upper gastrointestinal (GI) cancer based at South Tyneside District Hospital and the RVI. Not only does he assess patients in South Tyneside but he also accompanies them to the RVI to operate on them.

He said: “We are part of this hub and spoke system, although we are slightly different because I go with the patients from South Tyneside, I operate on them, and then bring them back here”.

Mr Wynne explains the situation to patients and their families at South Tyneside District Hospital.

“Patients are getting the best of both worlds”, he said.

“They have the specialist services, but have a familiar face going with them. It makes a huge difference.”

The endoscopy unit in South Tyneside also has a complete staging centre, at which various scans and tests are conducted before surgery. It is the only unit other that the RVI to have an endoscopic ultra-sound machine.

Patients from other trusts have to go to the RVI for their staging investigations.

That means patients are diagnosed and staged for treatment in South Tyneside much quicker than anywhere else, normally within a week.

Mr Wynne said: “Other hospitals diagnose there is a cancer but they can’t assess the severity of it as quickly as we can”.

The Trust sees an average of 60 new patients with stomach and gullet cancer each year, but only 15 to 20 need surgery. The rest receive palliative treatment.

(c) 2008 The Journal – Newcastle-upon-Tyne. Provided by ProQuest Information and Learning. All rights Reserved.

JACKSONVILLE, Fla., July 8, 2008 (PRIME NEWSWIRE) — BodyTel Scientific Inc. (OTCBB:BDYT), a developer and manufacturer of wireless telemedical systems, announces today that it has finalized the mass production of all GlucoTel Starter Kit components including GlucoTel Blood Glucose Test Strips and is now preparing the kitting of its first market ready product. After having obtained CE approval on May 28th 2008, BodyTel has already commenced supplies of its innovative blood glucose monitoring and management system GlucoTel to selected partners in CE sensitive countries. GlucoTel will be commercially available in Germany, the Netherlands and the United Arab Emirates (U.A.E.) by August 18th.

Stefan Schraps, CEO of BodyTel, stated, “This is the dawn of a new age for BodyTel. Over the last two years we have been a development stage company, preparing the comprehensive GlucoTel system for regulatory approval and commercial launch. To see the ‘GlucoTel’ blood glucose meter sitting in its starter kit and to see the internet platform ‘BodyTel Center’ as well as the cell phone application ‘BodyTel Mobile’ running so smoothly, fills my heart with pride. From August 18th on, BodyTel will no longer be a development stage company, but an active market player. This is a very exciting time for all of us!”

The GlucoTel system is a complete telemedical blood glucose monitoring and diabetes management system, supporting patients and healthcare professionals in the treatment and control of diabetes and other associated disorders. GlucoTel electronically measures the blood sugar level and sends it automatically via Bluetooth to the patient’s cell phone. Measured values are automatically transmitted from the cell phone to BodyTel’s online database via mobile internet connection and stored on a long-term basis in the patient’s secured profile. To facilitate better diabetes management, the patient and any authorized persons, e.g. healthcare professionals or other caregivers, can access the database ‘BodyTel Center’ at www.bodytel.com via the internet at any time using a secure login.

The GlucoTel system is the first system of its kind that can provide real-time monitoring and management through its optional alarm functions. If defined by the caregiver, the BodyTel Center can create an alert message (e.g. via text message or email) that can be sent to caregivers informing them immediately of a potential out-of-range result or other unusual behavior like not performing any test within a predefined time frame. The versatility of the system provides all these tools, but use is completely optional and can be enabled or disabled, based on patient, caregiver or healthcare professional requirements, preventing possible serious complications if action is taken without delay.

About BodyTel

BodyTel is a German-American telehealth company that specializes in telemedical monitoring and management systems for chronic diseases. The company combines its know-how in telecommunications, internet and medical technology/diagnostics to create new products and services for the changing needs of global health. BodyTel products are designed not only to simplify home monitoring by patients, but also to ease the communication of measured body values to healthcare professionals or other caregivers by bridging the gap between the patient and the caregivers instantaneously and in real-time. BodyTel’s products — GlucoTel, PressureTel and WeightTel are each at different stages of development and approval processes. Further information can be found at www.bodytel.com.

Forward Looking Statements

Statements in this news release that are not historical are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects,””plans,””anticipates,””believes,””intends,””estimates,””projects,””aims,””potential,””goal,””objective,””prospective,” and similar expressions, or that events or conditions “will,””would,””may,””can,””could” or “should” occur. Forward-looking statements in this news release include: is now preparing the kitting of its first market ready product, GlucoTel will be commercially available in Germany, the Netherlands and the United Arab Emirates (U.A.E.) by August 18th, and that From August 18th on, BodyTel will no longer be a development stage company, but an active market player. It is important to note that the Company’s actual outcomes may differ materially from those statements contained in this press release. Factors which may delay or prevent these forward looking statements from being realized include, but are not limited to those concerning the timing of regulatory approval or commercialization of its products or the achievement of any other clinical, regulatory or product development milestones or other risk factors and matters set forth in the Company’s Annual Report on Form 10-KSB for the year ended February 28, 2007 and the Company’s periodic reports filed with the SEC. These reports are available on our investor relations website at www.bodytel.com and on the SEC’s website at http://www.sec.gov. BodyTel undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

This news release was distributed by PrimeNewswire, www.primenewswire.com

 CONTACT: BodyTel Europe GmbH          Michaela Klinger          +49 (0)5621 96776 11          [email protected]           Chain Relations          Torsten Herrmann          06192/96-166-80          [email protected]           ZA Consulting Inc.          US Investor Relations          David Zazoff          212-505-5976 

GOLDEN, Colo., July 8 /PRNewswire/ — Summit Doppler Systems, a leading manufacturer of ultrasound Doppler products, introduced today a significant upgrade to the Vista AVS, a full-featured arterial physiologic exam system. The new Vista AVS has advanced features, one of which allows clinicians to perform the ankle brachial index (ABI) exam for the diagnosis of peripheral arterial disease (P.A.D.) in the seated position, the patent-pending Seated ABI.

The ABI exam, which compares systolic blood pressures obtained at the ankles and arms, was traditionally performed with the patient in the supine position to prevent error from hydrostatic pressure. This position requirement made the exam difficult for patients with disabilities or mobility impairments. Recent studies have shown these patients have reduced access to many diagnostic exams. Fortunately, the new Vista AVS calculates ABI values for seated patients by compensating for the effects of gravity on the lower extremity pressures. Now for the first time, patients who are immobile or unable to lay supine can be seated for ABI measurement.

“Our vision is to significantly broaden the availability of the ABI exam without compromising accuracy,” said Dave Jones, Vice President of Engineering for Summit Doppler. “With the Seated ABI, we are making the ABI exam readily available to millions of people who have mobility issues or medical conditions that prohibit testing in the supine position. The Seated ABI is the first of a series of steps we’re making toward delivery of a faster and more affordable ABI exam.”

Along with the ability to perform the Seated ABI using hydrostatic pressure correction, the new Vista AVS allows clinicians to customize segmental studies by selecting the number and location of arterial sites. While the ABI exam is performed as the initial test to diagnose P.A.D., segmental studies are performed on patients with P.A.D. to localize the occlusion in the lower limbs.

P.A.D. affects 8 to 12 million people in the U.S. every year. It is characterized by the narrowing of the arteries in the legs caused by plaque build-up, also known as atherosclerosis. Early detection can prevent further cardiovascular events, such as heart attack, stroke and death. Awareness of P.A.D. and its diagnosis and treatment are rapidly increasing. Better equipment and reimbursement for the diagnosis is making the exam cost effective for office-based medical practices.

The Vista AVS, first released in 2007, was designed by Summit Doppler to make the ABI and other arterial exams faster, easier, and more affordable. With its new features and significant cost advantage, the 2008 Vista AVS will broaden the availability of arterial diagnostic studies and help reduce overall healthcare costs.

Summit Doppler Systems, located in Golden, Colorado, manufactures ultrasound Doppler systems used to detect fetal heartbeat and monitor peripheral arterial blood flow. With continuous research and development, Summit Doppler is dedicated to providing new technologies to better serve the needs of healthcare providers, which ultimately provide improved healthcare for all of us.

http://www.summitdoppler.com/

Summit Doppler Systems

CONTACT: Julie A. Bolkovac, Director of Marketing of Summit DopplerSystems, Inc., 1-800-554-5090, ext. 230, fax, +1-303-940-7165,[email protected]

Web site: http://www.summitdoppler.com/

IN SHORT

What: Inside NZ: Insatiable Hunger

Where: TV3

When: 9.30pm, Thursday

——————–

NEW Zealand may have a growing obesity problem, but for the young people in Inside NZ: Insatiable Hunger, their weight issues really aren’t their fault.

They suffer from a disease where their stomachs are unable to tell their brains that they are full, and they always think that they are starving. Insatiable Hunger follows four Kiwi families with children suffering from the devastating effects of Prader-Willi syndrome.

Despite the obvious shortcomings of a disease that puts sufferers in danger of literally eating themselves to death, Prada-Willi syndrome is coupled with other cruel side- effects. Low muscle tone limiting exercise and a slow metabolism make overeating even more dangerous, while behavioural problems make life even harder for sufferers’ loved ones, who are already dealing with padlocking food in the cupboard and keeping sufferers out of rubbish bins.

Each year two Kiwi children are diagnosed with this non- inherited lifelong and life-threatening disease. It does not discriminate between race or gender, and it is not known what causes it. Ironically, the disease which will cause these children to balloon begins with stunted growth, and stunted development.

Though Prada-Willi syndrome has no known cure, regular growth hormone injections have been proven to reduce fat and improve muscle tone, significantly helping with obesity and related complications. Yet though these injections are funded in other countries, Kiwi kids face an ongoing battle trying to qualify for the treatment in New Zealand. Pharmac, the government drug-governing agency, has strict criteria for funding the treatment, which many Prada-Willi syndrome kids do not fit into.

Inside New Zealand: Insatiable Hunger follows four young people suffering from the disease at different stages of their lives. Tiny, doll-like 18-month-old Amelia Reid, only sat up by herself at 14 months of age. Amelia needs to have the growth hormone treatment so she can have a chance at developing normally.

Three-year-old Cameron O’Reilly’s parents have been paying more than $10,000 a year for him to have the treatment. Cameron has finally nailed the art of walking, and with his growth hormone treatment has been able to graduate to the big kids’ section at kindy. However, this may be Cameron’s last year with free access to food and treats because the insatiable appetite will kick in sometime between now and five years old.

In Northland, 11-year-old Darcy Harris faces being shifted out of the mainstream education system because of the behavioural problems caused by the disorder. Stealing his classmates’ lunches and his violent outbursts are putting a lot of pressure on the staff at his small rural school.

Francie Thornton, 22, is of the old era of Prada-Willi syndrome sufferers. She is not eligible for the growth hormone treatment, and will be forced out of her sheltered flat if she can’t control her eating — and her temper. She is strictly monitored by minders, and should be on a 1000-calorie a day diet, but Francie is resourceful.

——————–

(c) 2008 Dominion Post. Provided by ProQuest Information and Learning. All rights Reserved.

DEAR DR. DONOHUE: I am 92 years old but still independent – I drive, cook and do necessary house jobs. My biggest problem is achalasia. Food cannot pass down my esophagus and get through the sphincter at its bottom to enter the stomach. Is there anything I can do to avoid the pain and trouble that come with swallowing? – E.M.

ANSWER: The esophagus is a long, muscular tube that runs from the throat to the stomach. Through it, food passes to the stomach. The muscles of the esophagus push food down the tube. At its bottom, right before it joins the stomach, is a circular, strong muscle called the sphincter, which keeps the esophagus closed to protect it against any upward splashing of stomach acid. In achalasia (ACHE-uh- LAY-zhuh), the muscle contractions of the esophagus are weak, so food and drink are not forcefully propelled through it. Furthermore, the sphincter at the bottom of the esophagus stays contracted. It doesn’t relax when food and drink reach it. That’s another reason why swallowing becomes such a chore.

Some achalasia patients find that nitrate medicines relax the sphincter and make swallowing less troublesome. An example of a nitrate is nitroglycerin, the medicine used for the chest pain of angina. Viagra, the medicine for erectile dysfunction, has also been helpful. Botox injections, performed through a scope passed into the esophagus through the mouth, are another standard treatment. Balloons can also be passed into the esophagus and inflated when they reach the sphincter region to open it up. And there are many surgical procedures also available.

Your doctor can tell you if your general health is good enough to tolerate any of these treatments.

READERS: Chronic fatigue syndrome is a common malady of the late 20th century and the 21st century. People who would like information on this syndrome can order the booklet that deals with it and its treatment. To obtain a copy, write to: Dr. Donohue – No. 304, Box 536475, Orlando, FL 32853-6475. Enclose a check or money order (no cash) for $4.75 U.S./$6 Can. with the recipient’s printed name and address. Please allow four weeks for delivery.

DEAR DR. DONOHUE: I am a 54-year-old woman in good health, a nonsmoker and not overweight. I observe a diet and exercise program. I also take a low-dose aspirin daily. It has come to my attention that this regimen could be problematic and perhaps cause a rebound effect should I discontinue the aspirin. And what if I need surgery? I thought I was being proactive and was fending off heart disease and strokes. Have I painted myself into a corner instead? – S.S.

ANSWER: People take aspirin to prevent clots from forming in heart (heart attack) or brain (stroke) arteries. Stopping aspirin doesn’t foster clot formation.

Most operations can be carried out without fear in an aspirin user.

For men and women who have had a stroke or a heart attack, a daily aspirin definitely lessens the risk for having a second stroke or heart attack. This is called secondary prevention.

Primary prevention is aspirin use by people who have not already suffered a heart attack or stroke. People who are at risk of having either are the ones targeted for such treatment. Risks include such things as a family history of strokes or heart attacks at young ages, diabetes, high blood pressure, obesity, high cholesterol and physical inactivity. Men age 40 and older and who have two risk factors benefit from low-dose aspirin. Men age 50 and older and who have one risk factor benefit from low-dose aspirin. Women don’t need primary prevention until age 65. Aspirin protects men better than women from heart attacks and women better than men from strokes.

DEAR DR. DONOHUE: After reading your advice to the woman who had heel pain from plantar fasciitis, I was surprised you didn’t mention orthotics. They solved my heel pain. – M.A.

ANSWER: M.A. and many other readers wrote to suggest orthotics (specially made shoe inserts), heel pads, arch supports and cushioned insoles for the relief of heel pain from plantar fasciitis. The plantar fascia is a sling of tough tissue that runs from the heel to the toes on the bottom of the feet. Inflammation of that tissue is a common cause of heel pain.

Dr. Donohue regrets that he is unable to answer individual letters, but he will incorporate them in his column whenever possible. Readers may write him or request an order form of available health newsletters at P.O. Box 536475, Orlando, FL 32853- 6475. Readers may also order health newsletters from www.rbmamall.com

(c) 2008 Sun-Journal Lewiston, Me.. Provided by ProQuest Information and Learning. All rights Reserved.

For people who have suffered major heart surgery, the thought of taking up exercise and changing one’s lifestyle can be a daunting prospect. For more than a year and a half, the Community Cardiac Rehabilitation Service has been helping people who have had heart attacks, angioplasts, bypass grafts and heart valve replacements, get into appropriate fun and important exercise classes. The Grimsby Telegraph caught up with the team.

“THE course is the start of getting your life back.”

After a heart attack Alan Dixon cautiously, but enthusiastically, took part in a group exercise class at Grimsby’s Diana, Princess of Wales Hospital, aiming to get back into shape.

He has not looked back. Two years later, he is not only enjoying regular exercise, he is a volunteer helper on a Community Cardiac Rehabilitation Programme run by specialist cardiac nurse Liz Horner and cardiac exercise specialist Chris Kelly.

Former Whitgift School teacher and Franklin College lecturer Mr Dixon (59), from Station Road in Healing, said: “I found that the first course I did was just the start. I think the course is the start of getting your life back after having, in my case, a heart attack.

“In many ways, while you have to do some work, the exercise is easy because of the social and fun side, and because they can become routine. I wanted to volunteer here, because I wanted to put something back in.”

Weeks after major heart surgery to widen a faulty heart valve, Nicki Trushell joined an exercise class of strangers to get back on the road to recovery. Now, 10 months down the line she does three exercise sessions a week and is a regular sight jogging up and down Cleethorpes promenade.

She credits the Community Cardiac Rehabilitation programme for giving her a much better outlook on life. She holds it in such high regard that she now also volunteers on the programme.

Mrs Trushell (60), of Sandringham Road, Cleethorpes, said: “It is a good way of getting out and mixing, because everyone is in the same boat. It is a nice atmosphere.

“Now, I go out running. I run up and down the promenade, I really enjoy it. I didn’t think I would be as fit as this at all. It is unbelievable.

“The sessions are very important because they pick you up. You are not at home sat on your own.

“The course has made me look at life in a completely different way. It has made me realise, ‘you have got a life, get out there and live it’. We have a joke and a giggle here.

The service was set up in October 2006 thanks to grants from the British Heart Foundation and the Big Lottery. Longer term, the project will be supported by North East Lincolnshire Care Trust Plus.

After heart surgery, patients will meet with Community Cardiac Rehabilitation Nurse Specialist for North East Lincolnshire Liz Horner. A full cardiac rehabilitation assessment, called Phase II, is undertaken by Liz where risk factors are addressed and relevant lifestyle advice is given. Phase III is the six-week group exercise and education sessions.

They are held at Cleethorpes and Grimsby Leisure Centres and are free. Liz was quick to praise Sports and Leisure Management, which runs the venues, for their support.

At the first session of the six-week course, each patient is pre- assessed by undertaking a step test. Throughout the course, heart rate, weight, blood pressure and other details are taken and recorded.

Each exercise session is followed by a relaxation and stretching session and ends in a group education session with invited speakers.

Liz said: “Its not just about getting people to exercise. It’s about improving their confidence, both psychologically and physically. Once something like this happens people are worried about whether they can exercise and get back to a normal life again and return to work. This programme gives them the confidence to do that.”

When each patient has completed the six week Phase III programme, Liz then refers them onto the Steps programme – where for pounds2 per session they can access a 10-week supervised and tailored exercise programme at either Grimsby Swimming Pool, Grimsby, Cleethorpes Leisure or Immingham Leisure Centres.

Now the service is looking to work with the hospital to provide an integrated cardiac rehabilitation service for all patients in North East Lincolnshire.

Jim Locke (58), of Milton Road, on the Nunsthorpe estate, had an angioplasty on February 28. He is halfway through the six-week exercise programme.

He said: “I knew I had to improve my fitness. I have been out of work for a year because of my health. The only way to get back to work was to get fit again.

“If I had known how much I would enjoy these classes, I would have done them years ago.

“I didn’t look forward to the first session. I thought exercise was something I hadn’t done for a while, since my army days. But, I have enjoyed it and it has been fun.

George Dales (67), who lives at Scartho Top, had three stents fitted into his arteries.

He said: “The classes have been challenging and fun. I enjoy them. It has been nice to meet the other people in the class. After the course is over, I am going to continue exercising. I think I will do a mixture of things, including swimming.”

Fred Soper (71), who lives on Humberston Fitties, had a triple heart bypass some years ago, and he has recently had a stent fitted.

He said: “The programme is brilliant. It gets you back moving again. It has made me realise I have muscles which I haven’t used for a while.

“It is nice to have the expert help, rather than doing it on your own. I think it is easy to vegetate when you get a little bit older, especially if you have had something like heart surgery.”

Find out more

For more information about the group, call (01472) 874111.

(c) 2008 Grimsby Telegraph. Provided by ProQuest Information and Learning. All rights Reserved.

ANN ARBOR, Mich., July 8 /PRNewswire/ — NanoBio(R) Corp., a biopharmaceutical company focused on developing and commercializing novel products to prevent and treat infectious diseases, today announced the appointment of Daniel B. Dubin, M.D., to its board of directors.

Dr. Dubin currently serves as Vice Chairman and a Director at Leerink Swann, a leading healthcare and biotechnology investment banking firm.

“Dan’s keen understanding of the life sciences investment banking field and his clinical experience as a dermatologist bring a dual perspective that will help us create value and distinction as an emerging company in the biotechnology sector,” said James R. Baker Jr., founder and Chairman of NanoBio. “His expertise and informed perspective in the field of dermatology will greatly enhance the strategic positioning of our topical treatments for herpes labialis, onychomycosis and other dermatologic infections.”

A Harvard-trained dermatologist, Dr. Dubin served as Ambulatory Medical Director of the dermatology practice at Brigham and Women’s Hospital. In 1996, Dr. Dubin co-founded MEDACorp to provide life science companies and institutional investors with expert insight into the development and adoption of biopharmaceuticals, medical devices and diagnostics. When MEDACorp merged with Leerink Swann in 2001, Dr. Dubin became a Director at Leerink Swann and later assumed the position of Vice Chairman. Dr. Dubin also serves on the board of Eleme Medical, a cellulite treatment company.

NanoBio’s lead products are topical lotions and mucosal vaccines to combat a wide array of viruses, bacteria and fungi. The company’s nanoemulsion-based products have demonstrated potent antimicrobial effects in several phase 1 and 2 clinical trials without safety concerns or systemic absorption. The products use a physical mode of action rather than chemical synthesis to disrupt pathogen membranes, rendering the emergence of drug resistance unlikely.

About NanoBio

NanoBio(R) Corp. is a privately held biopharmaceutical company focused on developing and commercializing anti-infective products and mucosal vaccines derived from its patented NanoStat(TM) technology platform. The company’s lead product candidates are treatments for herpes labialis (cold sores), onychomycosis (nail fungus), MRSA and mucosal vaccines for influenza and hepatitis B. The company’s headquarters and laboratory facilities are located in Ann Arbor, Mich.

NanoBio Corp.

CONTACT: John Coffey, Vice President, Business Development of NanoBioCorporation, +1-734-302-9107, [email protected]

Sidney Kimmel, Founder and Chairman of The Sidney Kimmel Foundation for Cancer Research, has announced the appointment of Theodore Lawrence, M.D., Ph.D. to the Medical Advisory Board of the Kimmel Scholar Award program.

Theodore S. Lawrence, M.D., Ph.D., Isadore Lampe Professor of Radiation Oncology, is the Chair of the Department of Radiation Oncology and a professor in the Department of Environmental Health, School of Public Health at the University of Michigan. Dr. Lawrence is the Chair of the National Cancer Institute Board of Scientific Councilors (Clinical and Epidemiology) and a member of the Institute of Medicine of the National Academy of Sciences. He is an editor of The Cancer Journal: Journal of the Principles and Practice of Oncology, associate editor for Seminars in Radiation Oncology, and editor-in-chief of Translational Oncology. Dr. Lawrence is also past president of the American Society of Therapeutic Radiology and Oncology, and has served on the Board of Directors of the American Society of Clinical Oncology, the largest oncology society in the world.

Dr. Lawrence joined the faculty of the University of Michigan as an Assistant Professor in 1987, following a fellowship in medical oncology and a residency in radiation oncology at the National Cancer Institute. He received his research degree in cell biology from the Rockefeller University in New York, followed by his medical degree from Cornell University and an internal medicine residency at Stanford University. He was promoted to Associate Professor in 1992 and to Professor in 1997. He became the Isadore Lampe Professor and chair of the department in 1999. He is the author of over 150 peer-reviewed manuscripts and 20 book chapters. He is an editor, along with Drs. DeVita and Rosenberg, of the 8th edition of The Principles and Practice of Oncology.

In 1993 Sidney Kimmel established the Sidney Kimmel Foundation and the Sidney Kimmel Foundation for Cancer Research. Since that time, the Foundation has awarded more than $495 million to various philanthropic causes, primarily in the areas of cancer research, the performing arts and Jewish continuity. Through the Foundation, Mr. Kimmel has been particularly dedicated to the fight against cancer, funding leading research centers and promising young investigators. He has also been personally active in these efforts, chairing the national March on Washington, D.C. in 1998 to demand greater federal funding for cancer research.

The Sidney Kimmel Foundation for Cancer Research is specifically dedicated to improving the understanding of cancer biology and to developing new methods for the prevention and treatment of cancer. The Kimmel Scholar Awards were created in 1997 to advance the careers of gifted, young scientists involved in cancer research. Scientists are selected who show the greatest promise and innovation, but whose careers have not evolved sufficiently to provide them the critical mass of prior research that typically justifies receiving major grants from the National Cancer Institute and other funding sources. A total of 160 talented cancer researchers have been provided with grant money since the Foundation’s inception with each receiving a $200,000 award to further a specific cancer research project. Many of the exceptional young scientists who have their careers ‘jump started’ by the Sidney Kimmel Foundation for Cancer Research go on to receive millions of dollars in funding from the NCI and NIH and make significant contributions to the field of cancer research. Many report that they might never have achieved such success without first receiving the Kimmel grant.

Sidney Kimmel is the founder and Chairman of the Board of Jones Apparel Group and president of Sidney Kimmel Entertainment. Among many awards, Mr. Kimmel received the first-ever Medal of Honor for Cancer Philanthropy from the American Cancer Society in 2006. He has also received the American Cancer Society’s Humanitarian Award in 1999, the American Jewish Committee’s National Human Relations Award in 2000, and the Musser Award for Excellence in Leadership from Temple University in 2002.

The Sidney Kimmel Foundation for Cancer Research has also funded four cancer centers at San Diego, Memorial Sloan Kettering Cancer Center, Thomas Jefferson University and Johns Hopkins University. The gift to Johns Hopkins, $150 million, is the largest gift ever received by that institution. In the area of arts and culture, The Kimmel Foundation has supported the Kimmel Center for the Performing Arts in Philadelphia as well as the United States Holocaust Memorial Museum in Washington D.C., among others. For more information visit www.kimmel.org.

BOSTON, July 8 /PRNewswire/ — NorthPoint Domain, an IC Sciences company, announced today a collaboration with Boston Medical Center’s (BMC) Cardiovascular Center to apply advanced Internet patient engagement “instruments” to BMC’s cardiac robotic surgery program. Also known as “medical informatics instruments” (MIIs), these patient engagement tools are used by clinicians as informational and interactive tools that involve patients and their families in the care process. Built upon a web platform, informatics instruments represent a new way for clinicians to deliver medical care, making it feasible to educate and instruct patients and their families, set expectations, share decision-making, and support self-care in ways heretofore not possible.

The partnership unites the industry’s most potent cardiovascular patient engagement instruments with one of the most innovative cardiac surgery programs in the country, and is an extension of the long-standing relationship between NorthPoint Domain and the BMC Cardiovascular Center. The organizations have collaborated since 2002 to use web-based MIIs to advance patient-centered care. NorthPoint Domain will work with the Cardiovascular Center to tailor its MII platforms, complementing the advanced robotic surgery technology currently being used at BMC. “NorthPoint Domain will greatly enhance our ability to inform and engage our patients and make them true partners in their own care,” said Robert S. Poston, MD, Chief of Cardiac Surgery at BMC and Associate Professor of Cardiothoracic Surgery at Boston University School of Medicine.

Rony Sellam, President and Chief Operating Officer of NorthPoint Domain, added, “While BMC is among a handful of medical centers in the country offering minimally invasive robotic CABG, it will be the only center in the world combining this with our Internet instruments for informatics-powered care delivery.”

Healthcare participants use MIIs developed and delivered by IC Sciences and NorthPoint Domain to provide a new generation of healthcare — informed clinical care. This is patient-centered medicine enlightened and informed by MII-generated experience, evidence, prediction, and preference data. MIIs can provide potent functionality for partnering with and activating patients to participate in their care.

A burgeoning scientific evidence base, including a review of 24 randomized controlled trials, indicates that in chronic condition management patient engagement instruments achieve significant improvements not only in patient knowledge, care support, and behavioral outcomes, but also in clinical outcomes. (Murray et al) The partners expect to see similar benefits in the acute cardiac surgery care setting and are exploring future clinical studies to assemble an evidence base.

References

Murray E, et al. 2005. Interactive health communication applications for people with chronic disease. The Cochrane Database of Systematic Reviews Issue 4.

About IC Sciences Corporation

IC Sciences Corporation is a closely held, private organization pioneering in the medical information sciences and informed clinical technology markets. The company’s core business involves designing, developing, delivering, and advancing a series of informatics instrument classes, including care delivery, cognitive profiling, collective intelligence, therapeutic support, and performance evaluation. For more information, please visit http://www.icsciences.com/.

About NorthPoint Domain, Inc.

NorthPoint Domain, Inc., a subsidiary of IC Sciences Corporation, provides care delivery informatics instruments for the specialty specific medical practice. These Internet-based instruments are designed to engage patients, consumers, and referring clinicians, address health literacy concerns, and deliver patient care oversight. Please visit http://www.northpointdomain.com/ for additional information.

About the Cardiovascular Center at Boston Medical Center

Boston Medical Center is the primary teaching affiliate of the Boston University School of Medicine. The Cardiovascular Center is a regional referral center that uses state-of-the-art technology to provide high-quality, cost-effective cardiac and vascular care. The BMC Cardiovascular Center is the only hospital in Boston — and one of a handful in the United States — to offer minimally invasive robotically assisted coronary artery bypass surgery. For more information about the BMC Cardiovascular Center, please visit http://www.bmc.cardiologydomain.com/.

   CONTACT: IC Sciences Corporation            One Joy Street Boston, MA 02108            [email protected]            1-800-603-1420  

IC Sciences Corporation

CONTACT: IC Sciences Corporation, +1-800-603-1420,[email protected]

Web site: http://www.northpointdomain.com/http://www.bmc.cardiologydomain.com/

With Hepatitis C now an epidemic in California prisons, a class action lawsuit was filed today in Federal Court which would require the California Department of Corrections and Rehabilitation to provide thousands of inmates suffering from Hepatitis C with the proper diagnostic testing and treatment that they are currently being denied.

Filed by the downtown Los Angeles firm of Khorrami, Pollard & Abir, the suit contends that the CDCR is wrongly excluding thousands of inmates from liver biopsies and anti-viral treatment and allowing their disease to progress to more advanced stages of liver damage. The lack of proper diagnostic testing and treatment further spreads the disease among the inmate population.

Hepatitis C currently infects about 40% of the approximately 190,000 inmates in California prisons. The standard of care as set by the Center for Disease Control, the National Institute of Health and most medical practitioners requires that patients with Stage II Hepatitis be offered treatment. However, the CDCR requires inmates to develop a more advanced stage of Hepatitis C (compared to the general civilian population) before offering them antiviral treatment. At these more advanced stages, treatment is less likely to succeed. Moreover, many California inmates do not receive even the liver biopsies necessary to determine the stage of their disease.

Without treatment, a significant percentage of Hepatitis C patients will develop cirrhosis, liver failure, and cancer of the liver. Hepatitis C is the principal cause of liver failure and the main reason for liver transplantation in the United States.

“A court already decided the appropriate punishment for these people. The Department of Corrections is playing judge, jury, and executioner and doling out a punishment that no court would allow. This is unacceptable, inhumane and constitutes cruel and unusual punishment, which is prohibited by the Eighth Amendment to the Constitution,” says Khorrami.

The case has been filed on behalf of lead plaintiff, Kevin Jackson, currently an inmate at the California State Prison at Solano and names as a defendant Robin Dezember, the Director of the Division of Correctional Health Care Services who is responsible for establishing health care policies for the prison system in California.

Jackson was diagnosed with Stage II Hepatitis on August 27, 2007, and although he has repeatedly requested treatment, the CDCR has refused.

Hepatitis C is a serious viral infection of the liver, spread by contamination with blood from infected persons such as occurs through illicit intravenous drug use, tattoos, or contaminated therapeutic blood products. There are about six genetic strains of Hepatitis C.

Fortunately, good and effective treatment is available with a combination of two drugs, ribavirin and interferon.

“Despite an established standard of care, the California Department of Corrections and Rehabilitation has adopted protocols designed to exclude patients from diagnostic biopsies and treatment. This is in contrast to the care and treatment provided to the general population,” says Khorrami. “This practice not only denies inmates proper care and allows their health to deteriorate, but also presents a health danger of further spreading the disease not only within the prison population but also in the general population once the infected inmates are released from prison.”

 Shawn Khorrami Law Offices of Khorrami, Pollard & Abir 444 S. Flower St., 33rd Floor, Los Angeles, CA 310-308-9423 Email Contact  For press information, contact:  D. Infusino 310-497-2476  

SOURCE: Khorrami, Pollard & Abir, LLP

BRADENTON, Fla. _ Main ingredients in fresh salsa such as jalapeno, cilantro and Serrano peppers have become the lead suspects in a salmonella outbreak initially blamed on certain types of raw tomatoes.

When the investigation began more than two months ago, the Centers for Disease Control and the U.S. Food and Drug Administration issued an advisory, warning consumers against eating raw red plum, red Roma and round red tomatoes unless they were grown and harvested in states that appeared on a safe-to-eat list.

But as the investigation went on and consumers continued to become ill, investigators began to look elsewhere. The CDC and FDA expanded the investigation last week to include foods commonly served with tomatoes after noting clusters of people who became ill from eating at restaurants in Texas and other states.

Since mid-April, almost 1,000 people in 40 states have been infected with salmonella poisoning, according to the CDC. Cases highly concentrated in Texas, New Mexico and Illinois account for more than half of those reported in the outbreak.

Fresh salsa made with jalapeno, cilantro and Serrano peppers, rather than processed or canned salsas, are under scrutiny for the cause of the outbreak, according to the Wall Street Journal.

Liz Compton, spokeswoman for the Florida Department of Agriculture, also heard that investigators were looking at the various peppers, but have not ruled out tomatoes.

Frustration, especially for tomato growers, has mounted as the investigation has cost the industry millions of dollars. The investigation stalled shipments and harvesting, causing the fruit to go bad and customers to lose confidence in tomatoes.

Now that the lead is getting hotter for other types of produce, growers want to restore their reputation for producing a safe product.

“By expanding this investigation, wherever they look, we hope they quickly find the source and solve this,” Compton said.

To people in the tomato industry, the damage has already been done.

Reggie Brown, executive vice president of the Tomato Growers Exchange, said the new findings do not erase the loss of public confidence in tomatoes, nor does it undo the financial loss the industry suffered. Should the blame fall on peppers rather than tomatoes, it would be reasonable to expect financial restitution from the government, he said.

“Why they didn’t suspect other items and automatically went to the assumption it was tomatoes was unfortunate,” he said. “If that is, in fact, the result of the outcome, we’d be looking to the government to produce dollars to reaffirm public confidence and make the industry whole for the damage they caused.”

How soon, or if, the industry will bounce back completely, is debatable, Brown said.

“The quicker we get this behind us, the quicker the public will start to return to tomato consumption,” he said. “The public diet will improve and the industry will improve as soon as they say it’s not tomatoes.”

Local growers have remained focused on finding the source of the outbreak and putting into place a system to prevent the government from casting blame on an industry without proof.

Bob Spencer of West Coast Tomato said growers have believed all along that the cause of the outbreak was something other than fresh tomatoes from Florida. In 2007, Florida became the first state to implement a mandatory food safety program aimed at ensuring a safe product.

“We can only hope the FDA can learn from this mistake and change their practices and not try to cover up what has happened here to protect their reputation,” Spencer said. “They made a mistake, and hopefully they’ll be big enough to admit it.”

In the last few days, Spencer said information has circulated about various peppers as the cause of the outbreak, but he was leery of repeating it.

“You have to be careful about what you start hearing,” he said. “You don’t know what’s a rumor and what’s fact. The theme from this whole process is that American-grown produce is safe, and the consumer needs to demand it,” Spencer said.

While CNN has reported that U.S. investigators are focusing on imports from Mexico and plan Monday to stop shipments on the produce, the FDA and CDC had not issued an advisory to pull the produce from the shelves as of Saturday.

Local restaurants have continued to serve salsa by customer demand.

“We’re just pretty much waiting out the situation. You can’t do much about it,” said Jose Pallares, manager of Acapulco Mexican Restaurant, which includes fresh jalapeno and cilantro in its salsa.

The tomato advisory had people frustrated that salsa was no longer being served.

“When there was the whole tomato scare, we weren’t selling our salsa and people were actually ticked off about it,” Pallares said.

Customer reaction was the same at Moe’s Southwest Grill on University Parkway, said assistant manager Shane Doyle.

Moe’s corporate office pulled tomatoes as soon as the FDA and CDC issued the advisory and even waited 10 days after Florida was cleared.

“Every 15 minutes someone’s like, ‘You don’t have pico, you don’t have salsa?’ Yeah, it was bad,” he said.

___

(c) 2008, Bradenton Herald (Bradenton, Fla.).

Visit Bradenton Herald at http://www.bradenton.com/

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

National Surgical Hospitals, owner, operator and developer of surgical hospitals and surgery centers in partnership with local physicians, today announced that it recently acquired a 40% interest in Skyway Surgery Center in Chico, California. Majority ownership in the facility remains with the surgery center’s 20 physician partners.

The 12,600-square-foot multi-specialty surgery center, which opened in July 2004, has an emphasis on orthopedics and includes three operating rooms and two procedure rooms. It currently performs over 4,200 surgeries annually.

Commenting on the announcement, John G. Rex-Waller, Chairman, President and Chief Executive Officer of NSH, said, “We are very pleased to announce our affiliation with the physicians of Skyway Surgery Center, which represents our fifth surgery center in California and ninth in total. This partnership underscores the increasing reach of our operations and our philosophy of building strong and lasting relationships with our physician partners so together, we can always offer patient-friendly, efficient and cost-effective healthcare to in our communities.”

Commenting on the agreement, Dr. Ray Yip, one of the managing partners for the physician group, said, “Offering a broad range of services in the areas of center management, operations and marketing, together with deep knowledge of the industry, National Surgical Hospitals has earned a reputation as a leader in the surgery industry. We anticipate that NSH will provide solid leadership and direction for Skyway as we strive to accomplish our mission to deliver the highest possible level of healthcare to our patients in a convenient and pleasant outpatient setting. We look forward to a long-lasting relationship with NSH as we work together to grow our center.”

National Surgical Hospitals is the innovative healthcare partner that empowers physicians to thrive in a changing marketplace. NSH has operational surgical hospitals located in Arizona, Idaho, Michigan, New Mexico, North Carolina, Texas, Utah, Wisconsin, and Wyoming. Aside from its focus on surgical hospitals, NSH has operational orthopedic-focused surgery centers located in Arizona, California, Michigan and Texas. NSH has a strong pipeline of additional opportunities under consideration.

For information about NSH and how it is pioneering a better way to deliver surgical care, visit the Company’s website at www.nshinc.com.

INDIANAPOLIS, July 8 /PRNewswire/ — Compliance with inhaled medications for asthma can improve clinical outcomes, as measured by reduced emergency room visits and inpatient hospitalizations, according to a retrospective study conducted by HealthCore, Inc., the health outcomes research subsidiary of WellPoint, Inc. This study shows that the best outcomes were achieved by members who were compliant with inhaled corticosteroids, the National Asthma Education and Prevention Program (NAEPP) preferred therapy for patients with moderate to severe and severe asthma. However, the study identified that the majority of patients who took inhaled medications were less compliant than those taking oral medications, which may have led to less optimal clinical outcomes. HealthCore recently presented the study comparing the effectiveness of various asthma controller medications for patients at the American Thoracic Society’s international conference in Toronto, Ontario.

Using administrative data and patient-reported outcomes, HealthCore evaluated the impact of the various therapeutic classes of controller medications used to treat persistent asthma. When taken in a compliant manner, the inhaled corticosteroids were shown to provide the highest value for the treatment of asthma. In the group of patients who were compliant with their inhaled corticosteroid regimen, the overall cost of care, emergency room utilization and inpatient hospitalizations were the lowest. In this analysis, patients in the oral asthma controller group were more likely to have inpatient and emergency room visits (OR=1.74; range: 1.02-2.99), and higher total health care costs ($235/yr). Study findings revealed that patient compliance with prescribed therapies is a critical part of successfully managing asthma, and that compliance was higher with members taking oral medications, particularly among children.

“While there is considerable controlled trial data on asthma controller medications, we sought to provide a more complete picture of how these therapies work for patients in their everyday lives,” said Sam Nussbaum, M.D., WellPoint chief medical officer and executive vice president. “Evidence-based interventions in the treatment of asthma will benefit patients. Most significantly, real-world clinical research can help doctors decrease the negative impact of asthma on patients, allowing them to lead fuller, more productive lives.”

According to a 2005 study on the burden of uncontrolled asthma, the illness takes a considerable economic toll on the U.S. health care system, costing an estimated $12.7 billion in 2002. Based on 2006 data, the U.S. Centers for Disease Control and Prevention estimates that 16.1 million adults and 6.8 million children in the U.S. currently have asthma. While consensus guidelines have been developed to optimally manage asthma, HealthCore’s data provide real-world evidence on which of these therapies and combinations can offer the best outcomes and improve overall quality of life for patients with mild, moderate and severe persistent asthma.

HealthCore undertook this study based upon a recommendation from WellPoint’s National Pharmacy and Therapeutics Committee, an independent body of physicians, clinicians, and pharmacists who advise WellPoint on its formulary decisions. To complete its study, HealthCore retrospectively analyzed the medical and pharmacy claims data of more than 55,000 patients from eight U.S. health plans who had used one of six types of asthma controller medications between 2003 and 2005. These data were integrated with quality of life surveys of more than 800 asthma patients from the same plans to evaluate potential differences in quality of life between the types of controller medications. The study was conducted in collaboration with a scientific steering committee consisting of individuals recommended by the American Academy of Family Physicians, the American Academy of Pediatrics and the American Association of Allergy and Immunology.

Study researchers found that among patients on a one-drug controller regimen, oral asthma controller medications offered better clinical outcomes for some members, attributable to improved patient compliance on these medications compared to inhaled asthma medications. When compliance with medication was not controlled, patients in the oral asthma controller group were less likely to have inpatient and emergency room visits (odds ratio (OR) =0.80; range: 0.72-0.88), and less likely to use .6 rescue medication inhalers (OR=0.81; range: 0.74-0.88) than those in the inhaled medication group.

Both oral and inhaled treatments offered comparable impact on patient-reported quality of life and productivity. Among patients taking more than one drug to control their asthma, researchers found that a combination of inhaled corticosteroids and long-acting beta-agonists was the best course of treatment in terms of improved outcomes and improved quality of life.

“HealthCore’s data provided real-world evidence that patient compliance plays a major role in the overall effectiveness of asthma controller medications, with oral asthma controllers showing better compliance overall than asthma corticosteroid inhalants,” said Brian Sweet, chief clinical pharmacy officer, WellPoint, Inc. “In the case of a chronically managed disease, like asthma, where a patient takes medication daily, HealthCore’s ability to measure efficacy in the real world enables us to make more informed formulary decisions.”

HealthCore, a subsidiary of WellPoint, is a health outcomes and clinical research organization that has served the needs of health plans, government agencies, physician practices and pharmaceutical manufacturers since 1996. HealthCore focuses on providing evidence of the real-world safety and effectiveness of therapeutics; offering insight to best utilize this evidence; and communicating these findings to health care decision-makers. The company’s work is increasingly used to support evidence-based medicine, process improvement and patient-reported outcomes.

About WellPoint, Inc.

WellPoint, Inc. is the largest publicly traded commercial health benefits company in terms of membership in the United States. WellPoint, Inc. is an independent licensee of the Blue Cross Blue Shield Association and serves its members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as Blue Cross Blue Shield in 10 New York City metropolitan counties and as Blue Cross, Blue Shield or Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and through UniCare. Additional information about WellPoint is available at http://www.wellpoint.com/ .

WellPoint, Inc.

CONTACT: Media, Kristin Binns, +1-917-697-7802, or Investor Relations,Michael Kleinman, +1-317-488-6713, both of WellPoint, Inc.

Web site: http://www.wellpoint.com/

Confirma(R), pioneer of CADstream(R), a dedicated operating system for MRI, announced that it has expanded customer support by providing increased access to CME-accredited educational programs worldwide. In addition to delivering CADstream systems to over 1,000 customers throughout the world, Confirma also delivers exceptional customer training and access to education; helping physicians meet the growing demand for breast MRI.

Since CADstream’s introduction in 2003, Confirma has recognized the importance of providing comprehensive applications training and access to CME-accredited education programs. Breast MRI is a complex study that requires experience and expertise as well as advanced technology for analysis, interpretation and reporting. Confirma supports professional development in breast MRI through educational grants to organizations, including the International Center for Postgraduate Medical Education (ICPME) and The Scienomics Group. Education programs consist of a variety of online case review seminars, fellowships, and didactic and hands-on training workshops.

Increase in Demand for Breast MRI

While mammography and breast ultrasound are considered the gold standard for breast cancer detection, an increasing body of research data has demonstrated that breast MRI is an effective diagnostic and interventional tool. Demand for this important study has increased dramatically following the updated breast screening guidelines issued by the American Cancer Society and the publication of The New England Journal of Medicine study that demonstrated the efficacy of MRI in detection of contralateral cancers in patients diagnosed with breast disease.

The Need for Comprehensive Training and Education

Starting or expanding a breast MRI program can be challenging due to the significant amount of data produced, as well as the lack of standards in interpretation and the shortage of radiologists fully trained in the procedure.

“There are challenges associated with breast MRI and thus adequate training is essential,” said Dr. David Gruen, who is among the faculty for the online case review programs. “Educational programs, like those supported by Confirma, enable more radiologists to become proficient and help meet the increasing demand for this important procedure.”

Hands-on Courses

The hands-on courses, supported by Confirma, are intended to educate physicians and technologists who offer breast MRI examinations and perform MRI-guided breast biopsies. Educational objectives include: assessing the clinical role of breast MRI in patient selection and the detection, diagnosis, and management of breast disease; developing standardized post-processing techniques to determine the morphology and kinetics of lesions in breast MRI; and accurately interpreting and reporting breast MR images in accordance with the ACR BI-RADS(R). Participants also have the opportunity to review cases using CAD and practice MRI-guided biopsy techniques using a breast biopsy system.

The next hands-on course, Breast MRI Interpretation and Intervention, will take place in San Francisco, California, on July 11-12, 2008. The faculty will be Elise L. Berman, M.D., director of breast MRI, and Mary Perrine, RT (NM) (MRI), chief MRI technologist, Fairfax MRI, Fairfax, Virginia.

Confirma is also providing a grant along with Bayer Healthcare for a new educational program, Breast MRI Interpretation for Radiologists, led by Constance D. Lehman, M.D., Ph.D., director of radiology at the Seattle Cancer Care Alliance and professor of radiology at the University of Washington, and Gillian M. Newstead, M.D., professor of radiology and director of breast imaging at the University of Chicago. Visit http://www.icpme.us/CMS/biis.shtml for more details.

Several other hands-on courses are scheduled during 2008; visit http://www.confirma.com/edu-train_calendar.html for more information and a complete list of upcoming courses.

Fellowships

The fellowship program offers attendees peer-to-peer, hands-on education and training experience on location at expert sites throughout the country. Fellowships can be customized to meet individual customer training objectives. Email [email protected] for more information.

Online Case Reviews

Decisions in Medical Imaging — Breast MRI Analysis and Interpretation with CAD is a unique series of one-hour online case reviews using CAD to aid the radiologist in the analysis and interpretation of breast MRI studies. The next online session will take place on July 22, 2008 from 5:00 to 6:00 pm PT. The lecture and case review will be presented by Constance D. Lehman, M.D., Ph.D., director of radiology at the Seattle Cancer Care Alliance and professor of radiology at the University of Washington School Of Medicine. The review will cover the use of CAD for the interpretation of breast MR images as a complement to the radiologist’s initial interpretation. Dr. Lehman will detail how efficient post-processing and interpretation of the 1,000-2,000 images generated in a breast MR study can be achieved with the use of CAD software. There is no charge to attend the online case reviews. For more information, visit http://www.confirma.com/edu-train_calendar.html.

About Confirma, Inc.

Confirma provides peace of mind through leadership in innovative technology, customer support and resources for building and expanding an MRI practice. Confirma is the only company that develops and markets an operating system, CADstream, that is designed specifically for radiology networks and workflow-specific MRI applications. Confirma has revolutionized workflow and MRI study analysis and reporting through automated and standardized processing. Thousands of physicians at nearly 1,000 facilities partner with Confirma each day to provide premium patient care.

CADstream automates the analysis and interventional guidance of MRI studies, providing higher quality imaging studies, lower costs for radiology practices and improved communication tools for physicians and patients. In its initial application, CADstream was developed to assist in the analysis, interventional guidance and reporting of breast MRI studies. CADstream can be integrated into any workflow scenario and is compatible with all MRI scanners and PACS.

Confirma strives to exceed customer expectations through exceptional service. Confirma’s experienced customer support team is a resource for seamless service, as well as training and access to CME-accredited education programs that instill confidence and assist practices in achieving their goals.

For more information, visit www.confirma.com or call 877-811-2356.

Regulatory News:

The U.S. Food and Drug Administration (FDA) has approved Meda’s (STO:MEDAA) registration application for azelastine eye drops in unit dose (Optivar Unit Dose). The substance azelastine is an antihistamine and the eye drop formulation is approved for treatment of allergic conjunctivitis in adults and pediatrics.

Meda is conducting a broad development program for the azelastine substance, both as azelastine eye drops and azelastine nasal spray. Azelastine eye drops sample is one part of that development program.

MEDA AB (publ) is an international specialty pharma company that concentrates on marketing and market-adapted product development. Acquisitions and long-term partnerships are fundamental factors that drive the company’s strategy. Meda is represented with own organisations in 26 countries and with more than 1 500 employees within marketing and sales. Meda’s products are sold in approximately 120 countries world-wide. The Meda share is listed under Large Cap on the OMX Nordic Stock Exchange. Find out more, visit www.meda.se.

This information was brought to you by Cision http://newsroom.cision.com

Resurgent Health and Medical, a leader in automated handwashing and sanitizing technology, announced the launch of the CleanTracker at the Association for Professionals in Infection Control and Epidemiology (APIC) annual conference last week. The CleanTracker is the only fully functional RFID technology available to track handwashing compliance.

“At APIC we had interest from over 550 healthcare professionals and performed over 1300 handwashes with our machines,” said Jim Glenn, CEO of Resurgent Health and Medical. “With infection rates rising, mandatory reporting, and changes in reimbursement, healthcare facilities must do more to improve handwashing compliance to reduce HAIs.”

The CleanTracker software and RFID compliance monitoring technology is for use with Resurgent’s CleanTech IC automated handwashing systems. Users wash their hands and the CleanTech system and CleanTracker software do all the reporting. The easily navigated software gathers users’ data at the handwashing system and pushes the information to the database without intervention by an administrator.

The CleanTracker offers infection control departments streamlined hand hygiene data. The CleanTracker also offers the following benefits:

— Easily review reports of hand hygiene activity by a specified time period or by department, job title, or individual.

— Create and store quick reports for both past and current data.

— Generate simple graphs or tables for visual indications of hygiene events by department, job title or user.

— Automatically track hand washes that are complete or incomplete.

— Create customizable handwashing targets that can be assigned by department, job title or individual user to give staff a comparative record of hand hygiene compliance.

— User identity can easily be turned off to protect personal information.

The CleanTech touchless system performs a fully-automated twelve-second wash, sanitize and rinse cycle. Using Resurgent’s proprietary Chlorhexidine Gluconate (CHG) sanitizing solution, the single cycle removes over 99.9% of pathogens and continues to kill germs for up to six hours. The FDA certified CHG-based sanitizer contains mild skin conditioners to continuously improve skin health while removing dangerous germs.

The system further boosts compliance by ensuring a pleasant, uniform hand wash using high-pressure water jets that perform a consistent wash-and-sanitize cycle every time the machines are used.

About Resurgent Health & Medical

Resurgent Health and Medical delivers state of the art employee hygiene technologies to hospitals and healthcare facilities that are serious about infection prevention and the elimination of dangerous pathogens in the healthcare industry. Our patented CleanTech infection prevention technology brings science and precision to the process of removing dangerous microbes from hands. For almost 20 years, its CleanTech brand systems have been used worldwide in agriculture, food processing, food service, cleanroom manufacturing and healthcare. CleanTech uses up to 75% less water than manual handwashing, discharges 75% less wastewater, and reduces waste in soap utilization. For more information, visit http://www.resurgenthealth.com